0001137883
2000-09-23
2001-03-31
0001137883
us-gaap:CommonStockMember
2000-09-23
2001-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2000-09-23
2001-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2000-09-23
2001-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2000-09-23
2001-03-31
0001137883
2001-03-31
0001137883
us-gaap:CommonStockMember
2001-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2001-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2001-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2001-03-31
0001137883
2001-04-01
2002-03-31
0001137883
us-gaap:CommonStockMember
2001-04-01
2002-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2001-04-01
2002-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2001-04-01
2002-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2001-04-01
2002-03-31
0001137883
2002-03-31
0001137883
us-gaap:CommonStockMember
2002-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2002-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2002-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2002-03-31
0001137883
2002-04-01
2003-03-31
0001137883
us-gaap:CommonStockMember
2002-04-01
2003-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2002-04-01
2003-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2002-04-01
2003-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2002-04-01
2003-03-31
0001137883
2003-03-31
0001137883
us-gaap:CommonStockMember
2003-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2003-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2003-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2003-03-31
0001137883
2003-04-01
2004-03-31
0001137883
us-gaap:CommonStockMember
2003-04-01
2004-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2003-04-01
2004-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2003-04-01
2004-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2003-04-01
2004-03-31
0001137883
2004-03-31
0001137883
us-gaap:CommonStockMember
2004-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2004-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2004-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2004-03-31
0001137883
2004-04-01
2005-03-31
0001137883
us-gaap:CommonStockMember
2004-04-01
2005-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2004-04-01
2005-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2004-04-01
2005-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2004-04-01
2005-03-31
0001137883
2005-03-31
0001137883
us-gaap:CommonStockMember
2005-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2005-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2005-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2005-03-31
0001137883
2005-04-01
2006-03-31
0001137883
us-gaap:CommonStockMember
2005-04-01
2006-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2005-04-01
2006-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2005-04-01
2006-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2005-04-01
2006-03-31
0001137883
2006-03-31
0001137883
us-gaap:CommonStockMember
2006-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2006-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2006-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2006-03-31
0001137883
2006-04-01
2006-12-31
0001137883
us-gaap:CommonStockMember
2006-04-01
2006-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2006-04-01
2006-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2006-04-01
2006-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2006-04-01
2006-12-31
0001137883
2006-12-31
0001137883
us-gaap:CommonStockMember
2006-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2006-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2006-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2006-12-31
0001137883
2007-01-01
2007-12-31
0001137883
us-gaap:CommonStockMember
2007-01-01
2007-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2007-01-01
2007-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2007-01-01
2007-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2007-01-01
2007-12-31
0001137883
2007-12-31
0001137883
us-gaap:CommonStockMember
2007-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2007-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2007-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2007-12-31
0001137883
2008-01-01
2008-12-31
0001137883
us-gaap:CommonStockMember
2008-01-01
2008-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2008-01-01
2008-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2008-01-01
2008-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2008-01-01
2008-12-31
0001137883
2008-12-31
0001137883
us-gaap:CommonStockMember
2008-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2008-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2008-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2008-12-31
0001137883
2009-01-01
2009-12-31
0001137883
us-gaap:CommonStockMember
2009-01-01
2009-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2009-01-01
2009-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2009-01-01
2009-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2009-01-01
2009-12-31
0001137883
2009-12-31
0001137883
us-gaap:CommonStockMember
2009-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2009-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2009-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2009-12-31
0001137883
2010-09-30
0001137883
2010-01-01
2010-12-31
0001137883
us-gaap:CommonStockMember
2010-01-01
2010-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2010-01-01
2010-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2010-01-01
2010-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2010-01-01
2010-12-31
0001137883
2010-12-31
0001137883
us-gaap:CommonStockMember
2010-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2010-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2010-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2010-12-31
0001137883
2011-01-01
2011-03-31
0001137883
us-gaap:CommonStockMember
2011-01-01
2011-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2011-01-01
2011-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2011-01-01
2011-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2011-01-01
2011-03-31
0001137883
2011-01-01
2011-12-31
0001137883
us-gaap:CommonStockMember
2011-01-01
2011-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2011-01-01
2011-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2011-01-01
2011-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2011-01-01
2011-12-31
0001137883
2011-12-31
0001137883
us-gaap:CommonStockMember
2011-12-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2011-12-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2011-12-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2011-12-31
0001137883
2000-09-22
2011-12-31
0001137883
2012-01-01
2012-03-31
0001137883
us-gaap:CommonStockMember
2012-01-01
2012-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2012-01-01
2012-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2012-01-01
2012-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2012-01-01
2012-03-31
0001137883
2012-03-31
0001137883
2000-09-22
2012-03-31
0001137883
2000-09-22
0001137883
us-gaap:CommonStockMember
2000-09-22
0001137883
us-gaap:AdditionalPaidInCapitalMember
2000-09-22
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2000-09-22
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2000-09-22
0001137883
2011-03-31
0001137883
us-gaap:CommonStockMember
2011-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2011-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2011-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2011-03-31
0001137883
2000-09-21
0001137883
us-gaap:CommonStockMember
2012-03-31
0001137883
us-gaap:AdditionalPaidInCapitalMember
2012-03-31
0001137883
us-gaap:DeferredCompensationShareBasedPaymentsMember
2012-03-31
0001137883
bcli:DeficitAccumulatedDuringTheDevelopmentStageMember
2012-03-31
iso4217:USD
iso4217:USDxbrli:shares
xbrli:shares
BRAINSTORM CELL THERAPEUTICS INC
0001137883
Smaller Reporting Company
S-1
false
2012-03-31
1000
749000
93000
1923000
1145000
0
3664000
0
427000
312000
482000
59000
69000
148000
579000
2304000
1775000
1000
17000
17000
90000
109000
129000
91000
126000
146000
419000
314000
328000
1089000
2744000
2249000
307000
244000
325000
448000
750000
839000
531000
141000
126000
137000
0
1423000
1135000
1290000
125000
121000
142000
1548000
1256000
1432000
5000
6000
6000
39696000
45560000
45761000
40160000
44078000
44950000
68000
1000
84000
0
-17000
53000
1000
95000
0
-43000
21000
1000
110000
0
-90000
-31000
1000
131000
0
-163000
704000
1000
25101000
-5395000
-19003000
-7911000
1000
15803000
-1395000
-22320000
-1816000
1000
24427000
0
-26244000
-2428000
2000
30058000
0
-32488000
-2076000
3000
33881000
0
-35960000
-1743000
4000
35994000
0
-37741000
-459000
5000
39696000
0
-40160000
1488000
6000
45560000
0
-44078000
817000
0
0
0
0
0
2666000
6000
43525000
0
-40865000
6000
45761000
0
-44950000
1089000
2744000
2249000
0.00005
0.00005
0.00005
800000000
800000000
800000000
95832978
126444309
126737158
95832978
126444309
126737158
1045000
270000
1689000
24419000
369000
24788000
1544000
258000
2205000
17003000
510000
17513000
2589000
528000
3894000
41422000
879000
42301000
189000
-177000
-151000
-2547000
11000
-2536000
0
0
-132000
-132000
0
-132000
2400000
705000
3913000
43837000
868000
44705000
-19000
0
-5000
-77000
-4000
-81000
2419000
705000
3918000
43914000
872000
44786000
0
0
0
164000
0
164000
-17000
0
0
0
-17000
-26000
0
0
0
-26000
-47000
0
0
0
-47000
-73000
0
0
0
-73000
-18840000
0
0
0
-18840000
-3317000
0
0
0
-3317000
-3924000
0
0
0
-3924000
-6244000
0
0
0
-6244000
-3472000
0
0
0
-3472000
-1781000
0
0
0
-1781000
-2419000
0
0
0
-2419000
-705000
-705000
-3918000
0
0
0
-3918000
-44078000
-872000
0
0
0
-872000
-44950000
0.03
0.01
0.03
0.01
89094403
108895199
120117724
126591262
10100000
10100000
10100000
10238000
20867808
22854587
24201812
41004409
55241418
76309152
95832978
126444309
0
121034291
126737158
17506000
0
17506000
0
0
662000
0
662000
0
0
453000
0
453000
0
0
1446000
1446000
0
0
33000
0
33000
0
0
775000
0
775000
0
0
96000
0
96000
0
0
-20000
0
-20000
0
0
449000
0
449000
0
0
4000
0
4000
0
0
2025000
934904
1147225
544095
90000
5284284
443333
474203
0
0
5979000
-5979000
0
0
0
486000
-486000
0
1168000
0
1168000
0
0
1232000
0
1232000
0
0
731000
0
731000
0
0
409000
0
409000
0
0
388000
0
388000
0
0
27000
0
27000
0
0
1135000
0
1135000
0
0
177000
0
177000
0
0
200000
200000
200000
466667
2025040
135000
0
135000
0
0
137000
0
137000
0
0
140000
0
140000
0
0
402385
445617
755594
3000
0
3000
0
0
77000
0
77000
0
0
55000
0
55000
0
0
243000
0
243000
0
0
20000
0
20000
0
0
17399
1540885
94764
1648728
167849
214000
0
214000
0
0
0
0
0
0
0
0
0
0
0
0
11000
0
11000
0
0
272000
0
272000
0
0
0
0
0
0
0
3832621
1860000
3366783
3929446
1046834
125000
3602000
1000
3601000
0
0
14160933
0
0
0
0
0
24000
0
24000
0
0
24000
0
24000
0
0
2000001
10499999
10499999
17000
1000
16000
0
0
8500000
60000
0
60000
0
0
1600000
0
0
0
0
0
10100000
6000
0
6000
0
0
100000
0
0
0
0
0
0
0
0
0
-10062000
-1800000
60000
0
60000
0
0
8510000
8000
0
8000
0
0
11000
0
11000
0
0
15000
0
15000
0
0
15000
0
15000
0
0
7000
0
7000
0
0
1418000
0
1418000
0
0
2000000
1000
1999000
0
0
1500000
1000
1499000
0
0
1000
1000
0
0
0
1751000
1000
1750000
0
0
250000
0
250000
0
0
1894808
11500000
8625000
9916667
7250000
833333
584000
0
0
584000
0
1174000
0
51000
1123000
0
149000
0
149000
0
0
186875
99000
0
99000
0
0
165000
225000
0
225000
0
0
312500
135000
0
135000
0
0
187500
0
0
-3363000
3363000
0
-7906000
0
-7906000
7191000
0
7191000
0
0
164000
0
164000
0
0
1086000
0
1086000
0
0
407000
0
407000
0
0
0
0
-1395000
1395000
0
11000
0
11000
0
0
109000
0
109000
0
0
110000
0
110000
0
0
224000
0
224000
0
0
1276000
0
1276000
0
0
200000
0
200000
0
0
189000
0
189000
0
0
725881
3644610
2500000
1016109
400000
400000
2475000
201000
201000
281000
0
281000
0
0
729000
0
729000
0
0
455000
455000
0
0
0.00188
0.0375
0.065
0.01
25000000
0.75
0.1818
0.1818
0.80
0.60
0.80
0.80
0.1818
0.12
162000
38000
153000
1001000
38000
1039000
11000
-8000
-23000
12000
1000
13000
0
0
3000
451000
0
451000
0
0
0
1864000
0
1864000
0
0
0
795000
0
795000
96000
-20000
449000
21486000
4000
21490000
388000
27000
1135000
6821000
177000
6998000
400000
-265000
-105000
381000
249000
630000
45000
94000
-63000
717000
81000
798000
48000
254000
-64000
1397000
74000
1471000
0
0
0
6000
0
6000
-2069000
-55000
-2223000
-11347000
-746000
-12093000
0
0
0
23000
0
23000
-2069000
-55000
-2223000
-11370000
-746000
-12116000
5000
37000
48000
1133000
52000
1185000
0
0
0
-6000
0
-6000
6000
1000
-16000
-17000
0
-17000
1000
-36000
-64000
-1144000
-52000
-1196000
0
0
0
-16000
0
-16000
1000
-36000
-64000
-1160000
-52000
-1212000
2118000
3607000
3602000
12319000
0
12319000
0
0
0
2061000
0
2061000
-46000
0
0
88000
55000
515000
631000
20000
651000
0
0
0
601000
0
601000
2160000
3662000
4117000
14410000
20000
14430000
0
0
0
43000
0
43000
2160000
3662000
4117000
14453000
20000
14473000
92000
3571000
1830000
1923000
-778000
1145000
324000
137000
140000
0
487000
24000
24000
0
200000
0
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.9pt;">NOTE 1 -</td><td style="text-align: justify;">GENERAL:</td></tr></table><p style="margin: 0px; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">A.</td><td style="text-align: justify;"><font style="font-weight: normal;">Brainstorm Cell Therapeutics Inc. (formerly: Golden Hand Resources Inc.) (the "Company") was incorporated in the State of Washington on September 22, 2000.</font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B.</td><td style="text-align: justify;"><font style="font-weight: normal;">On May 21, 2004, the former major stockholders of the Company entered into a purchase agreement with a group of private investors, who purchased from the former major stockholders 6,880,000 shares of the then issued and outstanding 10,238,000 shares of Common Stock.</font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">C.</td><td style="text-align: justify;"><font style="font-weight: normal;">On July 8, 2004, the Company entered into a licensing agreement with Ramot of Tel Aviv University Ltd. ("Ramot"), to acquire certain stem cell technology (see Note 3). Subsequent to this agreement, the Company decided to focus on the development of novel cell therapies for neurodegenerative diseases based on the acquired technology and research to be conducted and funded by the Company.</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Following the licensing agreement dated July 8, 2004, the management of the Company decided to abandon all old activities related to the sale of the digital data recorder product. The discontinuation of this activity was accounted for under the provision of Statement of Financial Accounting Standard ASC 360-10 (formerly "SFAS" 144), "Accounting for the Impairment or Disposal of Long-Lived Assets".</font></p><p style="margin: 0px 0px 0px 84.45pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">D.</td><td style="text-align: justify;"><font style="font-weight: normal;">On October 25, 2004, the Company formed a wholly-owned subsidiary in Israel, Brainstorm Cell Therapeutics Ltd. ("BCT").</font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">E.</td><td style="text-align: justify;"><font style="font-weight: normal;">On November 22, 2004, the Company changed its name from Golden Hand Resources Inc. to Brainstorm Cell Therapeutics Inc. to better reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. BCT, as defined below, owns all operational property and equipment.</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">F.</td><td style="text-align: justify;"><font style="font-weight: normal;">On September 17, 2006, the Company changed the Company's fiscal year-end from March 31 to December 31. </font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">G.</td><td style="text-align: justify;"><font style="font-weight: normal;">In December 2006, the Company changed its state of incorporation from Washington to Delaware. </font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">H.</td><td style="text-align: justify;"><font style="font-weight: normal;">Since its inception, the Company has devoted substantially all of its efforts to research and development, recruiting management and technical staff, acquiring assets and raising capital. In addition, the Company has not generated revenues. Accordingly, the Company is considered to be in the development stage, as defined in Statement of Financial Accounting Standards No. 7, "Accounting and reporting by development Stage Enterprises" ASC 915-10 (formerly "SFAS No. 7").</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px; font: bold 10pt times new roman, times, serif; text-indent: 0px; text-align: justify;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><font style="font: 10pt times new roman, times, serif;"><b>I.</b></font></td><td style="text-align: justify;"><font style="font: 10pt times new roman, times, serif;">In October 2010, the Israeli Ministry of Health (“MOH”) granted clearance for a Phase I/II clinical trial using the Company’s autologous NurOwn™ stem cell therapy in patients with amyotrophic lateral sclerosis </font><font style="font: 10pt times new roman, times, serif;">(“ALS”), subject to some additional process specifications as well as completion of the sterility validation study for tests performed. </font></td></tr></table><p style="margin: 0px; font: bold 10pt times new roman, times, serif; text-indent: 0px; text-align: justify;"></p><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;">  </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"></td><td style="text-align: justify;"></td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"></td><td style="text-align: justify;"><font style="font-weight: normal;">On February 23, 2011, the Company submitted, to the MOH, all the required documents. Following approval of the MOH, a Phase I/II clinical study for ALS patients using the Company’s autologous NurOwn™ stem cell therapy (the “Clinical Trial”) was initiated in June 2011.</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"></p><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt/110% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 58.5pt;"></td><td style="width: 27pt;"></td><td style="text-align: justify;"><font style="color: black;">After the balance sheet date, in January 2012, the Company reported on an interim safety follow-up of the first 4 patients enrolled in its Clinical Trial indicating that no significant </font>treatment-related adverse events were reported. The NurOwn™ treatment has thus so far proven to be safe, and has shown some initial indications of beneficial clinical effects.</td></tr></table><p style="margin: 0px;">  </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt/110% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 58.5pt;"></td><td style="width: 27pt;"><b>J</b>.</td><td style="text-align: justify;">In February 2011, the U.S. Food and Drug Administration (“FDA”) granted orphan drug designation to the Company’s NurOwn™ autologous adult stem cell product candidate for the treatment of ALS.</td></tr></table><p style="margin: 0px 0px 0px 85.5pt; font: 10pt/110% times new roman, times, serif; text-indent: -27pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;"><b>GOING CONCERN:</b></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: left;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;">As reflected in the accompanying financial statements, the Company’s operations for the year ended December 31, 2011, resulted in a net loss of $3,918. The Company’s balance sheet reflects an accumulated deficit of $44,078. These conditions, together with the fact that the Company is a development stage Company and has no revenues nor are revenues expected in the near future, raise substantial doubt about the Company's ability to continue to operate as a going concern. The Company’s ability to continue operating as a “going concern” is dependent on several factors, among them is its ability to raise sufficient additional working capital.</p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;">In 2009, the Company decided to focus only on the effort to commence clinical trials for ALS and such trials did commence in 2011.</p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;">In February 2011, the Company raised approximately $3.8 million from institutional and private investors. However, there can be no assurance that additional funds will be available on terms acceptable to the Company, or at all.</p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: justify;">These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</p><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 1    -</td>
<td style="text-align: justify;">GENERAL</td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">A.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">Brainstorm Cell Therapeutics Inc. (formerly: Golden Hand Resources Inc.) (the "Company") was incorporated in the State of Washington on September 22, 2000.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">B.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On May 21, 2004, the former major stockholders of the Company entered into a purchase agreement with a group of private investors, who purchased from the former major stockholders 6,880,000 shares of the then issued and outstanding 10,238,000 shares of Common Stock.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">C.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 8, 2004, the Company entered into a licensing agreement with Ramot of Tel Aviv University Ltd. ("Ramot"), to acquire certain stem cell technology (see Note 4). Subsequent to this agreement, the Company decided to focus on the development of novel cell therapies for neurodegenerative diseases based on the acquired technology and research to be conducted and funded by the Company.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">Following the licensing agreement dated July 8, 2004, the management of the Company decided to abandon all old activities related to the sale of the digital data recorder product. The discontinuation of this activity was accounted for under the provision of Statement of Financial Accounting Standard ASC 360-10 (formerly "SFAS" 144), "Accounting for the Impairment or Disposal of Long-Lived Assets".</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">D.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On October 25, 2004, the Company formed a wholly-owned subsidiary in Israel, Brainstorm Cell Therapeutics Ltd. ("BCT").</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">E.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On November 22, 2004, the Company changed its name from Golden Hand Resources Inc. to Brainstorm Cell Therapeutics Inc. to better reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. BCT, as defined below, owns all operational property and equipment.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">F.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On September 17, 2006, the Company changed the Company's fiscal year-end from March 31 to December 31. </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">G.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">In December 2006, the Company changed its state of incorporation from Washington to Delaware. </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">H.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">Since its inception, the Company has devoted substantially all of its efforts to research and development, recruiting management and technical staff, acquiring assets and raising capital. In addition, the Company has not generated revenues. Accordingly, the Company is considered to be in the development stage, as defined in Statement of Financial Accounting Standards No. 7, "Accounting and reporting
by development Stage Enterprises" ASC 915-10 (formerly "SFAS No. 7").</font></td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">I.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">In October 2010, the Israeli Ministry of Health (“MOH”) granted clearance for a Phase I/II clinical trial using the Company’s autologous NurOwn™ stem cell therapy in patients with amyotrophic lateral sclerosis</font> (“<font style="font-weight: normal;">ALS”), subject to some additional process specifications as well as completion of the sterility validation study for tests performed. </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On February 23, 2011, the Company submitted to the MOH all the required documents. Following approval of the MOH, a Phase I/II clinical study for ALS patients using the Company’s autologous NurOwn™ stem cell therapy (the “Clinical Trial”) was initiated in June 2011. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In January 2012, the Company reported on an interim safety follow-up of the first 4 patients enrolled in its Clinical Trial indicating that no significant treatment-related adverse events were reported. The NurOwn™ treatment has thus so far proven to be safe, and has shown some initial indications of beneficial clinical effects.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt; text-align: left;"><b>J</b>.</td>
<td style="text-align: justify;">In February 2011, the U.S. Food and Drug Administration (“FDA”) granted orphan drug designation to the Company’s NurOwn™ autologous adult stem cell product candidate for the treatment of ALS.</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0; text-align: left;"><b> </b> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt;"><b>GOING CONCERN </b></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;">As reflected in the accompanying financial statements, the Company’s operations for the three months ended March 31, 2012, resulted in a net loss of $872. The Company’s balance sheet reflects an accumulated deficit of $44,950. These conditions, together with the fact that the Company is a development stage Company and has no revenues nor are revenues expected in the near future, raise substantial doubt about the Company's ability to continue to operate as a going concern. The Company’s ability to continue operating as a “going concern” is dependent on several factors, among them is its ability to raise sufficient additional working capital.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;">In 2009, the Company decided to focus only on the effort to commence clinical trials for ALS and such trials did commence in 2011.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;">In February 2011, the Company raised approximately $3.8 million from institutional and private investors. However, there can be no assurance that additional funds will be available on terms acceptable to the Company, or at all.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 58.5pt; text-align: justify;">These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</p>
<table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.9pt;"><b>NOTE 2 -</b></td><td><b>SIGNIFICANT ACCOUNTING POLICIES</b></td></tr></table><p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"></p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">A.</td><td style="text-align: justify;">Basis of presentation:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) applied on a consistent basis.</font></p><p style="margin: 0px 0px 0px 112.8pt; font: 10pt times new roman, times, serif; text-indent: -27.75pt; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B.</td><td style="text-align: justify;">Use of estimates:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">C.</td><td style="text-align: justify;">Financial statement in U.S. dollars:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The functional currency of the Company is the U.S dollar ("dollar") since the dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future. Part of the transactions of BCT are recorded in new Israeli shekels ("NIS"); however, a substantial portion of BCT’s costs are incurred in dollars or linked to the dollar. Accordingly, management has designated the dollar as the currency of BCT’s primary economic environment and thus it is their functional and reporting currency.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 (formerly Statement of Financial Accounting Standard 52), "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">D.</td><td style="text-align: justify;">Principles of consolidation:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, BCT. Intercompany balances and transactions have been eliminated upon consolidation.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">E.</td><td style="text-align: justify;">Cash equivalents:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">F.</td><td style="text-align: justify;">Property and equipment:</td></tr></table><p style="margin: 0px 85.05pt 0px 0px; font: 10pt times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The annual depreciation rates are as follows:</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p><table align="right" style="font: 10pt times new roman, times, serif; width: 83%; border-collapse: collapse;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="width: 56%; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;"> </td><td style="width: 39%;"><p style="margin: 0px; font: 10pt times new roman, times, serif; border-bottom: black 0.5pt solid; text-align: center;">%</p></td><td style="width: 5%;"> </td></tr><tr style="vertical-align: bottom;"><td style="direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;"> </td><td style="padding-left: 2.85pt; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: center;"> </td><td> </td></tr><tr style="vertical-align: bottom;"><td style="direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;">Office furniture and equipment</td><td style="padding-left: 2.85pt; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: center;">7</td><td> </td></tr><tr style="vertical-align: bottom;"><td style="direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;">Computer software and electronic equipment</td><td style="padding-left: 2.85pt; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: center;">33</td><td> </td></tr><tr style="vertical-align: bottom;"><td style="direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;">Laboratory equipment</td><td style="padding-left: 2.85pt; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: center;">15</td><td> </td></tr><tr style="vertical-align: bottom;"><td style="direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: left;">Leasehold improvements</td><td style="padding-left: 2.85pt; direction: rtl; line-height: 110%; unicode-bidi: embed; text-align: center;">Over the shorter of the lease term (including the option) or useful life</td><td> </td></tr></table><div> </div><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">  </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">G.</td><td style="text-align: justify;">Impairment of long-lived assets:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Company’s and BCT’s long-lived assets are reviewed for impairment in accordance with ASC 360-10 (formerly Statement of Financial Accounting Standard 144), "Accounting for the Impairment or Disposal of Long-Lived Assets," whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During 2010 and 2011, no impairment losses were identified.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">H.</td><td style="text-align: justify;">Research and development expenses, net:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Research and development expenses, are charged to the statement of operations as incurred.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Royalty-bearing grants from the Government of Israel for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. <font style="color: black;">Such grants are included as a deduction of research and development costs since at the time received it is not probable the Company will generate sales from these projects and pay the royalties resulting from such sales.</font></font></p><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">I.</td><td style="text-align: justify;">Severance pay:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><b> </b></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The liability of BCT for severance pay is calculated pursuant to the Severance Pay Law in Israel, based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date and is presented on an undiscounted basis.</font></p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt/4pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">BCT’s employees are entitled to one month's salary for each year of employment or a portion thereof. BCT’s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company's balance sheet.</font></p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt/4pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Severance Pay Law in Israel or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies.</font></p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt/4pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Severance expenses for the year ended December 31, 2011 were $20.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">J.</td><td style="text-align: justify;">Accounting for stock-based compensation:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Effective April 1, 2006, the Company adopted ASC 718-10 (formerly Statement of Financial Accounting Standards 123 (Revised 2004)), "Share-Based Payment,” which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options under the Company's stock plans based on estimated fair values. ASC 718-10 supersedes the Company's previous accounting under Accounting Principles Board Opinion 25, "Accounting for Stock Issued to Employees" ("APB 25"). In March 2005, the Securities and Exchange Commission issued Staff Accounting Bulletin 107 ("SAB 107") relating to ASC 718-10. The Company has applied the provisions of SAB 107 in its adoption of ASC 718-10. </font></p><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Company recognizes compensation expense for the value of non-employee awards, which have graded vesting, based on the accelerated attribution method over the requisite service period of each award, net of estimated forfeitures.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The Company recognizes compensation expense for the value of employee awards that have graded vesting, based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Company estimates the fair value of restricted shares based on the market price of the shares at the grant date and estimates the fair value of stock options granted using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are, expected stock price volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements over the period, equal to the expected option term. The expected option term was calculated for options granted to employees and directors in accordance with SAB 107 and SAB 110, using the "simplified" method. Grants to non-employees are based on the contractual term. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term. </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">K.</td><td style="text-align: justify;">Basic and diluted net loss per share:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Basic net loss per share is computed based on the weighted average number of shares outstanding during each year. Diluted net loss per share is computed based on the weighted average number of shares outstanding during each year, plus the dilutive potential of the Common Stock considered outstanding during the year, in accordance with ASC 260-10 (formerly Statement of Financial Accounting Standard 128), "Earnings per Share".</font></p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">All outstanding stock options and warrants have been excluded from the calculation of the diluted loss per share for the year ended December 31, 2011 and December 31, 2010, since all such securities have an anti-dilutive effect.</font></p><p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;">  </p><p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>L.</b></td><td style="text-align: justify;"><b>Income taxes:</b></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Company and BCT account for income taxes in accordance with ASC 740-10 (formerly Statement of Financial Accounting Standard 109), "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax asset and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company and BCT provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In September 2006, the Financial Accounting Standards Board ("FASB") issued ASC 740-10 (formerly FASB interpretation ("FIN") 48), "Accounting for Uncertainty in Income Taxes - an Interpretation of FASB Statement 109". ASC 740-10 establishes a single model to address accounting for uncertain tax positions. ASC 740-10 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. ASC 740-10 also provides guidance on recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The adoption of the provisions of ASC 740-10 did not have an impact on the Company's consolidated financial position and results of operations.</font></p><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>M.</b></td><td style="text-align: justify;"><b>Fair value of financial instruments:</b></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The carrying values of cash and cash equivalents, accounts receivable and prepaid expenses, trade payables and other accounts payable approximate their fair value due to the short-term maturity of these instruments.</font></p><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 2     -</td>
<td style="text-align: justify;">SIGNIFICANT ACCOUNTING POLICIES</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">The significant accounting policies applied in the annual financial statements of the Company as of December 31, 2011 are applied consistently in these financial statements.</p>
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.9pt;">NOTE 3 -</td><td style="text-align: justify;">RESEARCH AND LICENSE AGREEMENT</td></tr></table><p style="margin: 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On July 8, 2004, the Company entered into a research and license agreement (the "Original Agreement") with Ramot. The license agreement grants the Company an exclusive, worldwide, royalty-bearing license to develop, use and sell certain stem cell technology. In consideration of the license, the Company was required to remit an upfront license fee payment of $100; royalties at a rate of 5% of all net sales of products and 30% of all sublicense receipts. In addition, the Company granted Ramot and certain of its designees fully vested warrants to purchase 10,606,415 shares of Common Stock at an exercise price of $0.01 per share. The Company also agreed to fund, through Ramot, further research in consideration of $570 per year for an initial two-year period (“initial research period”). The Company also agreed to fund research for a further two-year period if certain research milestones are met for an additional $1,140 (“extended research period”). </font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The warrants issued pursuant to the agreement were issued to Ramot and its designees effective as of November 4, 2004. Each of the warrants is exercisable for a seven-year period beginning on November 4, 2005.</font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On March 30, 2006, the Company entered into an Amended Research and License Agreement with Ramot, for the purpose of amending and restating the Original Agreement. According to the agreement, the initial period was amended to an initial research period of three years. The Amended Research and License Agreement also extends the additional two-year research period in the Original Agreement to an additional three-year research period if certain research milestones are met. The Amended Research and License Agreement retroactively amended the consideration to $380 per year, instead of $570 per year. As a consequence, an amount of $300 was charged to the statement of operations as research and development expenses in the year ended in March 31, 2006. In addition, the Amended Research and License Agreement reduced royalties that the Company may have to pay Ramot, in certain cases, from 5% to 3% of net sales and also reduces the sublicenses receipt from 30% to 20%-25% of sublicense receipts.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On July 26, 2007, the Company entered into a Second Amended and Restated Research and License Agreement with Ramot. On August 1, 2007, the Company obtained a waiver and release from Ramot pursuant to which Ramot agreed to an amended payment schedule regarding the Company's payment obligations under the Amended Research and License Agreement, dated March 30, 2006, and waived all claims against the Company resulting from the Company's previous defaults and non-payment under the Original Agreement and the Amended Research and License Agreement. The payments described in the waiver and release covered all payment obligations that were past due and not yet due pursuant to the Original Agreement. The waiver and release amended and restated the remaining unpaid balance of $240 of the original payment schedule for the initial research period. </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;">As of December 24, 2009, the Company had not made the payments totaling $240. </font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 24, 2009, the Company and Ramot entered into a settlement under which, among other things, the following matters were agreed upon:</font></p><p style="margin: 0px 56.7pt 0px 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 21.3pt;">a)</td><td style="text-align: left;">Ramot released the Company from the Company’s obligation to fund the extended research period in the total amount of $1,140.Therefore, the Company removed an amount of $760 from its research and development expenses that had accumulated in the past.</td></tr></table><p style="margin: 0px 71.7pt 0px 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 71.7pt 0px 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 21.3pt;">b)</td><td style="text-align: justify;">Past due amounts of $240 for the initial research period plus interest of $32 owed by the Company to Ramot was converted into 1,120,000 restricted shares of common stock on December 30, 2009. Ramot deposited the shares with a broker and may sell the shares in the free market after 185 days from the issuance date.</td></tr></table><p style="margin: 0px 71.7pt 0px 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">In the event that the total proceeds generated by sales of the shares are less than $120 on or prior to September 30, 2010 ("September Payment"), then on such date the Company had to pay to Ramot the difference between the aggregate proceeds that had been received by Ramot up to such date, and $120. In the event that the total proceeds generated by sales of the shares, together with the September 30, 2010 payment, are less than $240 on or prior to December 31, 2010, then the Company had to pay to Ramot the difference between the proceeds that Ramot had received from sales of the shares up to such date together with the September Payment (if any) that had been transferred to Ramot up to such date, and $240. Related compensation in the amount of $51 was recorded as research and development expenses.</p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">As of December 31, 2011, Ramot had sold all 1,120,000 shares of Common Stock of the Company issued under the settlement agreement for $235. The Company paid the remaining balance of $5<font style="color: black;"> and finalized the balance due to Ramot according to the settlement agreement between the parties dated December 24, 2009</font>.</p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">In December 2011, the Company signed an agreement with BCT and Ramot, in which the Company assigned to BCT its rights under the License Agreement with Ramot, as well as its ownership rights in the joint patent application with Ramot. The Company guarantees all BCT obligations under the License Agreement towards Ramot.</p><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 4     -</td>
<td style="text-align: justify;">RESEARCH AND LICENSE AGREEMENT</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">The Company has a Research and License Agreement, as amended and restated, with Ramot. The Company obtained a waiver and release from Ramot pursuant to which Ramot agreed to an amended payment schedule regarding the Company's payment obligations under the Research and License Agreement and waived all claims against the Company resulting from the Company's previous defaults and non-payment under the Research and License Agreement. The waiver and release amended and restated the original payment schedule under the original agreement providing for payments during the initial research period and additional payments for any extended research period.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"> <font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">As of December 24, 2009, the Company had paid to Ramot $400 but did not make payments totaling $240 for the initial research period and payments totaling $380 for the extended research period. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On December 24, 2009, the Company and Ramot entered into a settlement agreement which amended the Research and License Agreement, as amended and restated pursuant to which, among other things, the following matters were agreed upon:</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">a)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Ramot released the Company from its obligation to fund the extended research period in the total amount of $1,140. Therefore, the Company deleted an amount in 2009, equal to $760 from it research and development expenses that were previously expensed.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Past due amounts of $240 for the initial research period plus interest of $32 owed by the Company to Ramot was converted into 1,120,000 shares of common stock on December 30, 2009. Ramot was required to deposit the shares with a broker and only sell the shares in the open market after 185 days from the issuance date.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">c)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">In the event that the total proceeds generated by sales of the shares on December 31, 2010, together with the March 31, 2010 payment, are less than $240 on or prior to December 31, 2010, then on such date the Company shall pay to Ramot the difference between the proceeds that Ramot has received from sales of the shares up to such date together with the September Payment (if any) that has been transferred to Ramot up to such date, and $240. Related compensation in the amount of $51 was recorded as research and development expenses.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In January 2011 Ramot exercised additional 167,530 Common Stock of the Company, for $35, which finalized the sale of the 1,120,000 Common Stock of the Company granted to Ramot for $235. In February 2011 the Company paid the remaining $5 and finalized the balance due to Ramot according to the settlement agreement between the parties dated December 24, 2009.</font></p>
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.9pt;">NOTE 4 -</td><td style="text-align: justify;">CONSULTING AGREEMENTS</td></tr></table><p style="margin: 0px; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">A.</td><td style="text-align: justify;"><font style="font-weight: normal;">On July 8, 2004, the Company entered into two consulting agreements with Prof. Eldad Melamed and Prof. Daniel Offen (together, the "Consultants"), upon which the Consultants shall provide the Company scientific and medical consulting services in consideration for a monthly payment of $6 each. In addition, the Company granted each of the Consultants, a fully vested warrant to purchase 1,097,215 shares of Common Stock at an exercise price of $0.01 per share. The warrants issued pursuant to the agreement were issued to the Consultants effective as of November 4, 2004. Each of the warrants is exercisable for a seven-year period beginning on November 4, 2005. As of December 31, 2010, the two Consultants exercised the above warrants to Common Stock of the Company.</font></td></tr></table><p style="margin: 0px 85.05pt 0px 0px; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B<font style="font-weight: normal;">.</font></td><td style="text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company approved a grant of 1,100,000</font><font style="font-weight: normal;">shares of the Company's Common Stock to the two Consultants, for services rendered through December 31, 2010. Related compensation in the amount of $220 was recorded as research and development expense. A sum of $487 was cancelled concurrently with the issuance of the 1,100,000 shares of Common Stock of the Company.</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">C<font style="font-weight: normal;">.</font></td><td style="text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company approved an additional grant of 400,000</font><font style="font-weight: normal;">shares of the Company's Common Stock to Prof. Daniel Offen, for services rendered through December 31, 2009. Related compensation in the amount of $192 is recorded as research and development expense.</font></td></tr></table><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 5    -</td>
<td style="text-align: justify;">CONSULTING AGREEMENTS</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">A.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 8, 2004, the Company entered into two consulting agreements with Prof. Eldad Melamed and Dr. Daniel Offen (together, the "Consultants"), under which the Consultants provide the Company scientific and medical consulting services in consideration for a monthly payment of $6 each. In addition, the Company granted each of the Consultants, a fully vested warrant to purchase 1,097,215 shares of Common Stock at an exercise price of $0.01 per share. The warrants issued pursuant to the agreement were issued to the Consultants effective as of November 4, 2004. Each of the warrants is exercisable for a seven-year period beginning on November 4, 2005. As of September 2010, all the above warrants had been exercised.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 58.5pt;"></td>
<td style="width: 27pt;"><b>B.</b></td>
<td style="text-align: justify;">On December 16, 2010, the Company approved a grant of 1,100,000 shares of the Company's Common Stock to the two Consultants, for services rendered through December 31, 2010. Related compensation in the amount of $220 was recorded as research and development expense. A sum of $487 was cancelled concurrently with the issuance of the 1,100,000 shares of Common Stock of the Company.</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.5pt; text-align: justify; text-indent: -27pt;"><b> </b></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 58.5pt;"></td>
<td style="width: 27pt; text-align: left;"><b>C.</b></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company approved an additional grant of 400,000</font> <font style="font-weight: normal;">shares of the Company's Common Stock to Prof. Daniel Offen, for services rendered through December 31, 2009. Related compensation in the amount of $192 is recorded as research and development expense.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">D.</td>
<td style="text-align: justify;"><font style="font-weight: normal;">As of March 31, 2012, the Company has a total obligation of $135 for services rendered by the Consultants under the abovementioned agreements.</font></td>
</tr>
</table>
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.9pt;">NOTE 8 -</td><td style="text-align: justify;">SHORT-TERM CONVERTIBLE NOTE</td></tr></table><p style="margin: 0px; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">On December 13, 2009, the Company issued a $135 Convertible Promissory Note to its legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the Note accrued at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.</p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">The gap between the amount the Company owed to the legal advisor and the principal of the Convertible Promissory Note in the amount of $82 was deducted from general and administrative expenses.</p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 58.5pt; font: 10pt/110% times new roman, times, serif; text-indent: -1.8pt; text-align: justify;">On February 19, 2010, the Company's legal advisor converted the entire accrued principal and interest of $135 Convertible Promissory Note into 402,385 shares of Common Stock.</p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">On September 15, 2010, the Company issued a $135 Convertible Promissory Note to its legal advisor for legal fees accrued through December 31, 2010. Interest on the Note was at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.</p><p style="margin: 0px 0px 0px 56.7pt; font: bold 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On February 18, 2011, the legal advisor converted the entire accrued principal and interest into 445,617 shares of Common Stock.</font></p><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;"><b>NOTE 6   -</b></td>
<td style="text-align: justify;"><b>SHORT-TERM CONVERTIBLE NOTE</b></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">On December 13, 2009, the Company issued a $135 Convertible Promissory Note to its legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the Note accrued at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">The gap between the amount the Company owed to the legal advisor and the principal of the Convertible Promissory Note in the amount of $82 was deducted from general and administrative expenses.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">On February 19, 2010, the Company's legal advisor converted the entire accrued principal and interest of $135 Convertible Promissory Note into 402,385 shares of Common Stock.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">On September 15, 2010, the Company issued a $135 Convertible Promissory Note to its legal advisor for legal fees accrued through December 31, 2010. Interest on the Note was at the rate of 4%. The legal advisor has the right at any time to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock based on the five day average closing stock price prior to conversion election.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;">On February 18, 2011, the legal advisor converted the entire accrued principal and interest into 445,617 shares of Common Stock.</p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt/11pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 0px;"></td>
<td style="width: 56.9pt;">NOTE 11 -</td>
<td style="text-align: justify;">STOCK CAPITAL</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 27pt; font: 10pt times new roman, times, serif; text-indent: -27pt; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">A.</td>
<td style="text-align: justify;">The rights of Common Stock are as follows:</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">Holders of Common Stock have the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company and the right to receive dividends, if declared.</p>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Common Stock is registered and publicly traded on the OTC Markets Group service of the National Association of Securities Dealers, Inc. under the symbol BCLI.</font></p>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">B.</td>
<td style="text-align: justify;">Issuance of shares, warrants and options:</td>
</tr>
</table>
<p style="margin: 0px; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">1.</td>
<td style="text-align: justify;">Private Placements:</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">a)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On June 24, 2004, the Company issued to investors 8,510,000 shares of Common Stock for total proceeds of $60 (net of $25 issuance expenses).</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 159.75pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On February 23, 2005, the Company completed a private placement for sale of 1,894,808 units for total proceeds of $1,418. Each unit consisted of one share of Common Stock and a three-year warrant to purchase one share of Common Stock </font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">at $2.50 per share. This private placement was consummated in three tranches which closed in October 2004, November 2004 and February 2005.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">c)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On May 12, 2005, the Company issued to an investor 186,875 shares of Common Stock for total proceeds of $149 at a price of $0.80 per share.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">d)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 27, 2005, the Company issued to investors 165,000 shares of Common Stock for total proceeds of $99 at a price of $0.60 per share.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">e)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On August 11, 2005, the Company signed a private placement agreement with investors for the sale of up to 1,250,000 units at a price of $0.80 per unit. Each unit consisted of one share of Common Stock and one warrant to purchase one share of Common Stock at $1.00 per share. The warrants were exercisable for a period of three years from issuance. On September 30, 2005, the Company sold 312,500 units for total net proceeds of $225. On December 7, 2005, the Company sold 187,500 units for total net proceeds of $135. </font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">f)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 2, 2007, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to 27,500,000 shares of Common Stock, for an aggregate subscription price of up to $5 million and warrants to purchase up to 30,250,000 shares of Common Stock. </font></td>
</tr>
</table>
<p style="margin: 0px; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">At each closing date, the Company would deliver to the investor the number of shares and warrants, subject to customary closing conditions and the delivery of funds, described above. The warrants had the following exercise prices: (i) the first 10,083,333 warrants had an exercise price of $0.20 per share; (ii) the next 10,083,333 warrants had an exercise price of $0.29 per share; and (iii) the final 10,083,334 warrants issued had an exercise price of $0.36 per share. All warrants expired on November 5, 2011. </font></p>
<p style="margin: 0px 0px 0px 143pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 143pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 18, 2009, the Company entered into an amendment to the investment agreement with the investor as follows:</font></p>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -27.1pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 143pt;"></td>
<td style="width: 27.1pt;"><font style="font-weight: normal;">(a)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The investor shall invest the remaining amount of the original investment agreement at a price per share of $0.12 in monthly installments of not less than $50 starting August 1, 2009.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 143pt;"></td>
<td style="width: 27.1pt;"><font style="font-weight: normal;">(b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The exercise price of the last 10,083,334 warrants will decrease from an exercise price of $0.36 per share to $0.29 per share. </font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 197.2pt; font: 10pt times new roman, times, serif; text-indent: -27.1pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 143pt;"></td>
<td style="width: 27.1pt;"><font style="font-weight: normal;">(c)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">All warrants will expire on November 5, 2013 instead of November 5, 2011.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: -27pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 144pt;"></td>
<td style="width: 27pt;"><font style="font-weight: normal;">(d)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The price per share of the investment agreement decreased from $0.1818 to $0.12, therefore the Company adjusted the number of Shares of Common Stock issuable pursuant to the investment agreement retroactively and issued to the investor on October 28, 2009 an additional 9,916,667 shares of Common Stock for past investment.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -27.1pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 143pt;"></td>
<td style="width: 27.1pt;"><font style="font-weight: normal;">(e)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The investor has the right to cease payments in the event that the price per share as of the closing on five consecutive trading days shall decrease to $0.05.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -27.1pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On January 18, 2011, the Company and the investor signed an agreement to offset amounts due to the investor, totaling $22, against the remaining balance of the investment. The Company issued to the investor 10,499,999 shares of Common Stock and a warrant to purchase 4,537,500 shares of the Company's Common Stock at an exercise price of $0.29 per share</font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2011, the Company issued to the investor and its designees an aggregate of 41,666,667 shares of Common Stock, a warrant to purchase 10,083,333 shares of the Company's Common Stock at an exercise price of $0.20 per share, and a warrant to purchase 20,166,667 shares of Common Stock at an exercise price of $0.29 per share. The warrants may be exercised at any time and expire on November 5, 2013. </font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In addition, the Company issued an aggregate of 1,250,000 shares of Common Stock to a related party as an introduction fee for the investment. </font></p>
<p style="margin: 0px 0px 0px 115.65pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: -0.9pt; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2011, the introduction fee was paid in full.</font></p>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.75pt;"></td>
<td style="width: 28.1pt;">(f)</td>
<td style="text-align: justify;">In January 2010, the Company issued 1,250,000 units to a private investor for total proceeds of $250. Each unit consisted of one share of Common Stock and a two-year warrant to purchase one share of Common Stock at $0.50 per share.</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 227.7pt; font: 10pt times new roman, times, serif; text-indent: -0.8in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.75pt;"></td>
<td style="width: 28.1pt;">(g)</td>
<td style="text-align: justify;">In February 2010, the Company issued 6,000,000 shares of Common Stock to three investors (2,000,000 to each investor) and warrants to purchase an aggregate of 3,000,000 shares of Common Stock (1,000,000 to each investor) with an exercise price of $0.50 for aggregate proceeds of $1,500 ($500 each). The warrants are exercisable through February 17, 2012.</td>
</tr>
</table>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.75pt;"></td>
<td style="width: 28.1pt;">(h)</td>
<td style="text-align: justify;">In February 2011, the Company issued 833,333 shares of Common Stock, at a price of $0.30 per share, and a warrant to purchase 641,026 shares of the Company's Common Stock at an exercise price of $0.39 per share exercisable for one year for total proceeds of $250.</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 171pt; font: 10pt times new roman, times, serif; text-indent: -27pt; text-align: left;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(i)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">In February 2011, the Company entered into an investment agreement, pursuant to which the Company sold 12,815,000 shares of Common Stock, for an aggregate subscription price of $3.6 million and warrants to purchase up to 19,222,500 shares of Common Stock as follows: warrants to purchase 12,815,000 shares of Common Stock at $0.50 for two years, and warrants to purchase 6,407,500 shares of Common Stock at $0.28 for one year.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">In July 2011, an investor exercised a warrant to purchase 946,834 shares of Common Stock of the Company at $0.28 per share, for $265.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"></td>
<td style="text-align: justify;"><font style="font-weight: normal;">In addition, the Company paid 10% of the funds received for the distribution services received. Out of this amount, 4% was paid in stock and the remaining 6% in cash. Accordingly, in March 2011, the Company issued 512,600 shares of Common Stock and paid $231 for the investment banking related to the investment.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">2.</td>
<td style="text-align: justify;">Share-based compensation to employees and to directors:</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">a)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Options to employees and directors:</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On November 25, 2004, the Company's stockholders approved the 2004 Global Stock Option Plan and the Israeli Appendix thereto (which applies solely to participants who are residents of Israel) and on March 28, 2005, the Company's stockholders approved the 2005 U.S. Stock Option and Incentive Plan, and the reservation of 9,143,462 shares of Common Stock for issuance in the aggregate under these stock option plans.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Each option granted under the plans is exercisable until the earlier of ten years from the date of grant of the option or the expiration dates of the respective option plans. The 2004 and 2005 options plans will expire on November 25, 2014 and March 28, 2015, respectively. The exercise price of the options granted under the plans may not be less than the nominal value of the shares into which such options are exercised. The options vest primarily over three years. Any options that are canceled or forfeited before expiration become available for future grants.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 5, 2008, the Company's stockholders approved an amendment and restatement of the Company’s 2004 Global Share Option Plan and 2005 U.S. Stock Option and Incentive Plan to increase the number of shares of common stock available for issuance under these stock option plans in the aggregate by 5,000,000 shares.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 27, 2005, the Company granted one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.75 per share. The options are fully vested and expire after 10 years.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On February 6, 2006, the Company entered into an amendment to the Company's option agreement with the Company's Chief Financial Officer. The amendment changes the exercise price of the 400,000 options granted to him on February 13, 2005 from $0.75 to $0.15 per share. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 2, 2006, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The options are fully vested and expire after 10 years. The compensation related to the options, in the amount of $48, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 22, 2006, the Company entered into an amendment to the Company's option agreement with two of its employees. The amendment changed the exercise price of 270,000 options granted to them from $0.75 to $0.15 per share. The excess of the fair value resulting from the modification, in the amount of $2, was recorded as general and administration expense over the remaining vesting period of the option.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On September 17, 2006, the Company entered into an amendment to the Company's option agreement with one of its directors. The amendment changes the exercise price of 100,000 options granted to the director from $0.75 to $0.15 per share. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On March 21, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $43, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: left;"><font style="font-weight: normal;">On July 1, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $38, was recorded as general and administrative expense. On October 22, 2007, the Company and the director agreed to cancel and relinquish all the options which were granted on July 1, 2007.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: left;">On July 16, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $75, was recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 27, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $84, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On October 23, 2007, the Company granted to its former Chief Executive Officer and director an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.87 per share. The option vests with respect to 1/6 of the option on each six month anniversary and expires after 10 years. The total compensation related to the option is $733, which is amortized over the vesting period as general and administrative expense. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On November 5, 2008, the Company entered into an amendment to the Company's option to purchase 1,000,000 shares of common stock agreement with the Company's CEO. The amendment changed the exercise price of the option from $0.87 to $0.15 per share. The compensation related to the modification of the purchase price in the amount of $4 was recorded as general and administrative expense.</font><font style="font-weight: normal;">In February 2011, the former CEO resigned. As of December 31, 2011, 300,727 out of the above options were exercised. After the balance sheet date, the former CEO exercised his option to purchase an additional 132,038 shares of common stock (see Note 15 C).</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 29, 2009, the Company granted to its former Chief Executive Officer and director an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.067 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $68, which is amortized over the vesting period as general and administrative expense. In February 2011, the former CEO resigned. On July 25, 2011, the Company signed a settlement agreement with the former CEO under which 483,333 shares out of the above grant became fully vested exercisable through April 30, 2012. An additional $30 was recorded as compensation in general and administrative expense. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal; font-family: times new roman, times, serif;">On June 29, 2009, the Company granted to its former Chief Financial Officer an option to purchase 200,000 shares of Common Stock at an exercise price of $0.067 per share. The option vested with respect to 1/3 of the shares subject to the option. Out of the above options, 2/3 were cancelled and the remaining 66,667 were exercised.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 31, 2009, the Company granted to two of its directors an option to purchase 100,000 shares of Common Stock for each of them at an exercise price of $0.15 per share. The option vests with respect to 1/3 of the option on each anniversary and expires after 10 years. The total compensation related to the option is $32, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 13, 2009, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $21, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On February 10, 2010, the Company granted to an employee an option to purchase 30,000 shares of Common Stock at an exercise price of $0.32 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $9, which is amortized over the vesting period as research and development expense. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 13, 2010, the Company, Prof. Abraham Israeli and Hadasit Medical Research Services and Development Ltd. (“Hadasit”) entered into an Agreement (the “Agreement”) pursuant to which Mr. Israeli agreed, during the term of the Agreement, to serve as (i) the Company’s Clinical Trials Advisor and (ii) a member of the Company’s Board of Directors.  In consideration of the services to be provided by Mr. Israeli to the Company under the Agreement, the Company agreed to grant options annually during the term of the Agreement for the purchase of its Common Stock, as follows:</font></p>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt/110% times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt/110% times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">*</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">An option for the purchase of 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share to Mr. Israeli; and</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 198.45pt; font: 10pt/110% times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt/110% times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">*</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">An option for the purchase of 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share to Hadasit.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 198.45pt; font: 10pt/110% times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt/110% times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">*</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Such options will vest and become exercisable in twelve (12) consecutive equal monthly amounts.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-indent: -2.25pt; text-align: left;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In April 2010, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option is $50, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option is $48, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In April 2010, the Company granted Hadasit an option to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option is $7, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In April 2011, the Company granted Hadasit an option to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option is $11, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company granted to two of its directors an option to purchase 400,000 shares of Common Stock at an exercise price of $0.15 per share. The options are fully vested and are exercisable for a period of 10 years. The compensation related to the option, in the amount of $78, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-indent: -2.25pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company approved the grant to two Board members an option to purchase 400,000 shares of Common Stock of the Company (200,000 shares each). The compensation related to the option, in the amount of $80, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company approved the grant to its three Scientific Board members 300,000 shares of Common Stock of the Company. The compensation related to the option, in the amount of $60, was recorded as research and development expense</font>.</p>
<p style="margin: 0px; font: 10pt/110% times new roman, times, serif; text-align: right;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company granted to its employees options to purchase 670,000 shares of Common Stock at an exercise price of $0.18 per share. The options are vested over three years and are exercisable for a period of 10 years. The compensation related to the option, in the amount of $32, was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company granted to its CEO, an option to purchase 450,000 shares of Common Stock of the Company at $0.20. The total compensation related to the option is $177, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company granted to four of its directors an option to purchase 634,999 shares of Common Stock of the Company at $0.15. The total compensation related to the option is $287, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 10, 2011, the Company granted to its CEO, an option to purchase 70,000 shares of Common Stock of the Company at $0.20. The total compensation related to the option is $26, which was amortized as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On November 10, 2011, the Company approved the grant to its four Advisory Board members an option to purchase 500,000 shares of Common Stock of the Company (125,000 shares each). The total compensation related to the option is $140, which is amortized over the vesting period as general and administrative expense</font>.</p>
<p style="margin: 0px 0px 0px 2in; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On November 10, 2011, the Company approved the grant to a former director of the Company 250,000 shares of Common Stock of the Company. The compensation related to the option, in the amount of $70, was recorded as general and administrative expense</font>.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2011, 1,825,103 options are available for future grants.</font></p>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">A summary of the Company's option activity related to options to employees and directors, and related information is as follows:</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<table style="width: 60%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="10">Year ended December 31, 2011</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Amount of<br />options</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Weighted <br />average <br />exercise <br />price</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Aggregate <br />intrinsic <br />value</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="text-align: center;" colspan="2"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">$</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">$</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 52%; text-align: left;">Outstanding at beginning of period</td>
<td style="width: 2%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;">6,893,024</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 2%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;">0.183</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 2%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;"> </td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">Granted</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,321,665</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.151</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">Exercised</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">(1,286,600</td>
<td style="text-align: left;">)</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.148</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-bottom: 2.5pt; text-align: left;">Cancelled</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">(1,989,268</td>
<td style="padding-bottom: 2.5pt; text-align: left;">)</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt; text-align: right;">0.188</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt; text-align: right;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-bottom: 2.5pt; text-align: left;">Outstanding at end of period</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">4,938,821</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">0.168</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">831,684</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-bottom: 2.5pt; text-align: left;">Vested and expected-to-vest at end of period</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">3,663,138</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">0.138</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">507,028</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal; font-size: 10pt;">*)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal; font-size: 10pt;">During 2008, the Company extended the exercise period for some of its employees that were terminated. The extension was accounted for as modification in accordance with ASC 718-10. According to ASC 718-10, modifications are treated as an exchange of the original award, resulting in additional compensation expense based on the difference between the fair value of the new award and the original award immediately before modification. Applying modification accounting resulted in additional compensation expense for the year ended December 31, 2008, amounted to $6.</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-align: justify;">The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the fair market value of the Company’s shares on December 31, 2011 and 2010 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2011 and 2010.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The options outstanding as of December 31, 2011, have been separated into exercise prices, as follows:</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<table style="width: 60%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold;"> </td>
<td style="font-weight: bold; text-align: center;" colspan="2">Options outstanding as of</td>
<td style="font-weight: bold;"> </td>
<td style="font-weight: bold;"> </td>
<td style="font-weight: bold; text-align: center;" colspan="2">Weighted average remaining</td>
<td style="font-weight: bold;"> </td>
<td style="font-weight: bold;"> </td>
<td style="font-weight: bold; text-align: center;" colspan="2">Options exercisable as of</td>
<td style="font-weight: bold;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">December 31,</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">contractual</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">December 31,</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;">Exercise price</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">2 0 1 1</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">Life</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">2 0 1 1</td>
<td style="font-weight: bold; padding-bottom: 1pt; vertical-align: middle; text-align: center;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;">$</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="text-align: justify;" colspan="2"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; vertical-align: middle; border-bottom: black 1pt solid; text-align: center;" colspan="2">Years</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="text-align: justify;" colspan="2"> </td>
<td style="padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; width: 31%; text-align: center;">0.00005</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 20%; text-align: right;">333,332</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 20%; text-align: right;">8.29</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 20%; text-align: right;">277,777</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.4pt; text-align: center;">0.067</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">586,217</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1.59</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">551,922</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: center;">0.15</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,384,272</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5.55</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,033,439</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.4pt; text-align: center;">0.18</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">670,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8.48</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">305,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: center;">0.2</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">520,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">9.51</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">70,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.4pt; text-align: center;">0.32</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8.12</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">10,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: center;">0.39</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">115,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5.50</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">115,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.4pt; text-align: center;">0.4</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">110,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4.48</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">110,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.4pt; text-align: center;">0.47</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">110,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5.22</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">110,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.4pt; text-align: center;">0.75</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">80,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3.18</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">80,000</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.65pt; padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 2.5pt;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: right;">4,938,821</td>
<td style="font-weight: bold; padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 2.5pt;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: right;">6.03</td>
<td style="font-weight: bold; padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 2.5pt;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="font-weight: bold; border-bottom: black 2.5pt double; text-align: right;">3,663,138</td>
<td style="font-weight: bold; padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 5.65pt; text-indent: 0in; text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-size: 10pt;">Compensation expense recorded by the Company in respect of its stock-based employee compensation award in accordance with ASC 718-10 for the year ended December 31, 2011 and 2010 amounted to $</font>1,135<font style="font-size: 10pt;"> and $388, respectively.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The fair value of the options is estimated at the date of grant using a Black-Scholes options pricing model with the following assumptions used in the calculation:</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="width: 60%; margin-left: 141.75pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="font-size: 10pt; text-align: center;"> </td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; font-size: 10pt; border-bottom: black 1pt solid; text-align: center;" colspan="6">Year ended December 31,</td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-size: 10pt; text-align: center;"> </td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; font-size: 10pt; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; font-size: 10pt; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td>
<td style="font-weight: bold; font-size: 10pt; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-size: 10pt; text-align: center;"> </td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: center;" colspan="2"> </td>
<td style="font-size: 10pt;"> </td>
<td> </td>
<td colspan="2"> </td>
<td> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="font-size: 10pt; text-align: left;">Expected volatility</td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">134%-141%</td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">134%-141%</td>
<td style="font-size: 10pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-size: 10pt; text-align: left;">Risk-free interest</td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">1.14%-2.93%</td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">2.26%-3.47%</td>
<td style="font-size: 10pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="font-size: 10pt; width: 56%; text-align: left;">Dividend yield</td>
<td style="font-size: 10pt; width: 1%;"> </td>
<td style="font-size: 10pt; width: 2%; text-align: left;"> </td>
<td style="font-size: 10pt; width: 17%; text-align: right;">0</td>
<td style="font-size: 10pt; width: 4%; text-align: left;">%</td>
<td style="font-size: 10pt; width: 2%;"> </td>
<td style="font-size: 10pt; width: 1%; text-align: left;"> </td>
<td style="font-size: 10pt; width: 16%; text-align: right;">0</td>
<td style="font-size: 10pt; width: 1%; text-align: left;">%</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-size: 10pt; text-align: left;">Expected life of up to (years)</td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">5-6</td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">6-10</td>
<td style="font-size: 10pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="font-size: 10pt; text-align: left;">Forfeiture rate</td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">0</td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt;"> </td>
<td style="font-size: 10pt; text-align: left;"> </td>
<td style="font-size: 10pt; text-align: right;">0</td>
<td style="font-size: 10pt; text-align: left;"> </td>
</tr>
</table>
<p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><b> </b></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Restricted shares to directors:</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 2, 2006, the Company issued to two of its directors 200,000 restricted shares of Common Stock (100,000 each). The restricted shares are subject to the Company's right to repurchase them at a purchase price of par value ($0.00005). The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. The compensation related to the stock issued amounted to $104, which was amortized over the vesting period as general and administrative expenses.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to a director 100,000 restricted shares of Common Stock. The restricted shares are subject to the Company's right to repurchase them at a purchase price of par value ($0.00005). The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. The compensation related to the shares issued amounted to $47, which was amortized over the vesting period as general and administrative expenses.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">In addition, on April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to another director 100,000 restricted shares of Common Stock. The restricted shares are not subject to any right to repurchase, and the compensation related to the shares issued amounted to $47 was recorded as prepaid general and administrative expenses in the three months ended March 31, 2007.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-align: left;">On August 27, 2008, the Company issued to its director 960,000 shares of Common Stock upon a cashless exercise by a shareholder of a warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $.01 per share that was acquired by the shareholder from Ramot. The shares were allocated to the director by the shareholder.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In May 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its directors 300,000 (total) restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In May and in June 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its Scientific Advisory Board members and two of its Advisory Board members 500,000 (total) restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On December 16, 2010, the Company granted to two of its directors 400,000 (total) shares of Common Stock. Related compensation in the amount of $80 was recorded as general and administrative costs in 2010. These shares were actually granted in June 2011, and an additional related compensation in the amount of $112 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 85.5pt; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 27, 2011, the Company granted to two of its directors 476,666 (total) shares of Common Stock, out of which 216,666 shares are fully vested and 260,000 shares will vest in 12 equal monthly installments through June 2012. Related compensation in the amount of $229 will be recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 22, 2011, the Company entered into an agreement with Chen Schor (the “Executive Director Agreement”) pursuant to which the Company granted to Mr. Schor 923,374 shares of restricted Common Stock of the Company.  The shares will vest over a three-year period. If the Company raises $10,000,000 of proceeds through the issuance of equity securities in a private or public offering after the Grant Date, or enters into a deal with a strategic partner that brings in at least $10,000,000 of gross proceeds, then 1/3 of the shares will vest upon such event, 1/3 will vest on the anniversary of the Grant Date and the remaining 1/3 will vest on the second anniversary of the Grant Date.  If such capital is not raised as mentioned above, then the shares will vest over 3 years – 1/3 upon each anniversary of the Grant Date.</font><font style="font-weight: normal;">In addition, the Company will pay $15,000 per quarter to Mr. Schor for his services as an Executive Board Member. </font></p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In August 2011, the Company issued to three of its Scientific Advisory Board members and three of its Advisory Board members a total of 300,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in equal monthly portions over the service period.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In November 2011, the Company issued to four of its Advisory Board members a total of 500,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in equal monthly portions over the service period.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In addition, in November 2011, the Company issued to a former director 250,000 shares of Common Stock. Related compensation in the amount of $70 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">3.</td>
<td style="text-align: justify;">Shares and warrants to service providers:</td>
</tr>
</table>
<p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px"><font style="font-weight: normal; font-size: 10pt;">The Company accounts for shares and warrant grants issued to non-employees using the guidance of</font><font style="font-weight: normal; font-size: 10pt;">ASC 505-50, "Equity-Based Payments to Non-Employees" (formerly 718-10, "Accounting for Stock-Based Compensation") and EITTF 96-18, "Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling, Goods or Services," whereby the fair value of such option and warrant grants is determined using a Black-Scholes options pricing model at the earlier of the date at which the non-employee's performance is completed or a performance commitment is reached.</font></p>
<p style="margin: 0px 0px 0px 113.4pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<p style="margin: 0px 0px 0px 113.4pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; margin-left: 56.37pt; text-align: left;">a)     Warrants: </p>
<p style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<table style="width: 100%; font: 8pt times new roman, times, serif;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;">Issuance date</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Number of <br />warrants <br />issued</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Exercised</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Forfeited</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Outstanding</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Exercise<br />Price $</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Warrants <br />exercisable</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Exercisable through</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 9%; text-align: left;">November 2004</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">12,800,845</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">11,747,497</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">151,803</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">901,545</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">0.01</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">901,545</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">November 2012</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">December 2004</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,800,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,800,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">—</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,894,808</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,894,808</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">47,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">47,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1.62</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">June 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">June 2015</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">August 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">70,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">70,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">September 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">September 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">36,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">36,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">September-December2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">December 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">20,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">20,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">December 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">457,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">150,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">307,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">307,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">December 2015</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.65</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2016</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">40,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">40,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">189,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">97,696</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">91,304</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0. 5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">May 2016</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May -December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.35</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May -December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">May 2016</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">June 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">24,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">24,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">19,355</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">19,355</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">630,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">630,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.3</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.47</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">March 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.47</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">March 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">15,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">15,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">15,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">225,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">225,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,300</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,300</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.39</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">July 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">September 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">August 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">August 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.2</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;" nowrap="nowrap">August-October2017</td>
<td style="text-align: left;"></td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">November 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.20</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">November 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">August 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">August 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">November 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">September 2018</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2019</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.067</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">66,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">October 2019</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">October 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">January 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">January 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.001</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">January 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">641,026</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">641,026</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.39</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">641,026</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">6,407,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">946,834</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5,460,666</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.28</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5,460,666</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2012</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2020</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">April 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">22,222</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2021</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-bottom: 1pt; text-align: left;">February 2010</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">1,500,000</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">1,500,000</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="text-align: right;">0.01</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">500,000</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="text-align: right;">February 2020</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">78,604,165</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">15,495,027</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">3,967,070</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">59,142,068</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">58,064,289</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
</table>
<p style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; text-align: left;"></p>
<p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p>
<div> </div>
<p></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The fair value for the warrants to service providers was estimated on the date of grant using a Black-Scholes option pricing model, with the following weighted-average assumptions for the year ended December 31, 2011 and December 31, 2010; weighted average volatility of 138% and 126%-165%, respectively, risk free interest rates of 1.69% and 0.37%-2.12%, respectively, dividend yields of 0% and a weighted average life of the options of 5.2 and 1-9 years, respectively.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Shares:</font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 1 and June 4, 2004, the Company issued 40,000 and 150,000 shares of Common Stock for 12 months of filing services and legal and due-diligence services, respectively, with respect to a private placement. Compensation expense related to filing services, totaling $26, was amortized over a 12-month period. Compensation related to legal services, totaling $105 was recorded as equity issuance cost and had no effect on the statement of operations.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On July 1 and September 22, 2004, the Company issued 20,000 and 15,000 shares to a former director for financial services for the first and second quarters of 2004, respectively. Related compensation in the amount of $39 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On February 10, 2005, the Company signed an agreement with one of its service providers under which the Company issued to the service provider 100,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In March and April 2005, the Company signed an agreement with four members of its Scientific Advisory Board under which the Company issued to the members of the Scientific Advisory Board 400,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan (100,000 each). All restrictions on these shares have lapsed. </font></p>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"><b> </b></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In July 2005, the Company issued to its legal advisors 50,000 shares for legal services for 12 months. The compensation related to the shares in the amount of $37.5 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In January 2006, the Company issued to two service providers 350,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed. Related compensation in the amount of $23 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On March 6, 2006, the Company issued to its legal advisor 34,904 shares of Common Stock. The shares are in lieu of $18.5 payable to the legal advisor. Related compensation in the amount of $18.5 was recorded as general and administrative expense. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 13, 2006, the Company issued to service providers 60,000 shares at a purchase price of $0.00005 par value under the U.S Stock Option and Incentive Plan of the Company. Related compensation in the amount of $25.8 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 170.1pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 9, 2006, the Company issued to its legal advisor 65,374 shares of Common Stock in lieu of payment for legal services. Related compensation in the amount of $33 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 7, 2006, the Company issued 50,000 shares of Common Stock for filing services for 12 months. Related compensation in the amount of $24.5 was recorded as general and administrative expense. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 5, 2006, the Company issued 200,000 shares to a finance consultant for his services. Related compensation in the amount of $102 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 14, 2006, the Company issued 200,000 shares to a service provider. Related compensation in the amount of $68 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On August 17, 2006, the Company issued 100,000 shares to a service provider. Related compensation in the amount of $35 was recorded as general and administrative expense.</font></p>
<p style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On September 17, 2006, the Company issued to its legal advisor 231,851 shares of Common Stock in lieu of $63 payable to the legal advisor. Related compensation in the amount of $63 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 1 and September 30, 2006, the Company issued to its business development advisor, based on an agreement, 240,000 shares of Common Stock. Related compensation in the amount of $74 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On January 3, 2007, the Company issued to its legal advisor 176,327 shares of Common Stock. The shares are for the $45 payable to the legal advisor. Related compensation in the amount of $49 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 12, 2007, the Company issued to its filing and printing service providers 80,000 shares of Common Stock. The shares issued are for the $15 payable to the service provider. Related compensation in the amount of $30 was recorded as general and administrative expense. In addition, the Company is obligated to issue the filing and printing service providers additional shares, in the event that the total value of the shares previously issued (as quoted on the Over-the-Counter Bulletin Board or such other exchange where the Common Stock is quoted or listed) is less than $0.20, on March 20, 2008. In no event shall the Company issue more than 30,000 additional shares to the service providers. As a result, the Company recorded a liability in the amount of $20.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 12, 2007, the Company issued to its legal advisor 108,511 shares of Common Stock. The shares are for $29 payable to the legal advisor. Related compensation in the amount of $40 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On May 18, 2007, the Company issued to its legal advisor 99,257 shares of Common Stock. The shares are for $33, payable to the legal advisor. Related compensation in the amount of $33 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On October 29, 2007, the Company issued to a Scientific Advisory Board member 80,000 shares of the Company’s Common Stock for scientific services. Compensation of $67 was recorded as research and development expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On May 20, 2008, the Company issued to its finance advisor 90,000 shares of the Company's common stock. The shares are for $35 payable to the finance advisor for introduction fee of past convertible loans. Related compensation in the amount of $36 is recorded as finance expenses.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On April 5, 2009, the Company issued to its Chief Technology Advisor 1,800,000 shares of Common Stock. The shares are for $180 payable to the advisor. Related compensation in the amount of $144 was recorded as research and development expense.</font></p>
<p style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On June 24, 2009, the Company issued to its public relations advisor 250,000 shares of Common Stock. The shares are for $25 payable to the advisor. Related compensation in the amount of $18 was recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On July 8, 2009, the Company issued to its finance consultant 285,714 shares of the Company's Common Stock. The shares are for $20 payable to the finance consultant for valuation of options and warrants. Related compensation in the amount of $20 is recorded as general and administrative expense.</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On July 15, 2009, the Company issued to its service provider 357,142 shares of the Company's Common Stock. The shares are for $25 payable to the service provider for filing services. Related compensation in the amount of $21 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On August 10, 2009, the Company issued to its service provider 71,428 shares of the Company's Common Stock. The shares are for $5 payable to the service provider for IT services. Related compensation in the amount of $4 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On October 1, 2009, the Company issued to its service provider 150,000 shares of the Company's Common Stock. The shares are for financial and investor relation services done by the provider. Related compensation in the amount of $51 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On October 2, 2009, the Company issued to its service provider 1,250,000 shares of the Company's Common Stock. The shares are for investor and public relation services. Related compensation in the amount of $400 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On December 30, 2009, the Company issued to Ramot 1,120,000 shares of the Company's Common Stock (see note 3).</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On December 13, 2009, the Company issued a $135 Convertible Promissory Note to it legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the note accrued at the rate of 4%.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">On January 5, 2010, the Company issued to its public relations advisor 50,000 shares of the Company's Common Stock for six months’ service. The issuance of the shares is part of the agreement with the public relations advisor that entitles it to a monthly grant of 8,333 shares of the Company's Common Stock</font>.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On January 6, 2010, the Company issued to its service provider 60,000 shares of the Company's Common Stock. The shares are for $15 payable to the service provider for insurance and risk management consulting and agency services for three years.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On February 19, 2010, the Company's legal advisor converted the entire accrued principal and interest amount outstanding under the note into 402,385 shares of Common Stock.</p>
<p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"><b> </b></p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">On April 6, 2010, Prof. Melamed fully exercised his warrant to purchase 1,097,215 shares of the Company’s Common Stock. The warrant was issued to him pursuant to the agreement with the Consultants effective as of November 4, 2004 (See Note 4a).</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In May 2010, based on a board resolution dated June 29, 2009, the Company issued to one of its public relations advisors 100,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On December 16, 2010, the Company granted to its service provider 200,000 shares of the Company's Common Stock. The shares are for investor and public relations services. Related compensation in the amount of $40 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On December 16, 2010, the Company granted to its Chief Medical Advisor 900,000 shares of the Company's Common Stock for services rendered through December 31, 2010. Related compensation in the amount of $180 is recorded as research and development expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On December 16, 2010, the Company granted to its Chief Scientist 200,000 shares of the Company's Common Stock for services rendered through December 31, 2010. Related compensation in the amount of $40 is recorded as research and development expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On February 18, 2011, the Company's legal advisor converted the entire accrued principal and interest of the Convertible Promissory Note granted on September 15, 2010, totaling $137, into 445,617 shares of Common Stock.</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">On June 27, 2011, the Company granted to its legal advisor 180,000 shares of Common Stock for 2011 legal services. Half of the shares of Common Stock are fully vested and half vest in six equal monthly installments through December 2011. Related compensation in the amount of $86 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">On June 27, 2011, the Company granted to its consultant 400,000 shares of the Company's Common Stock, for services rendered through December 31, 2009. Related compensation in the amount of $192 is recorded as research and development expense. (See note 4 C)</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">On June 27, 2011, the Company granted to a service provider 10,870 shares of the Company's Common Stock. Related compensation in the amount of $5 is recorded as general and administrative expense.</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">On December 31, 2011, the Company issued to Hadasit warrants to purchase up to 1,500,000 restricted shares of the Company's Common Stock at an exercise price of $0.001 per share, exercisable for a period of 5 years.  The warrants shall vest over the course of the trials as follows: 500,000 upon enrollment of 1/3 of the patients; an additional 500,000 upon enrollment of all the patients and the final 500,000 upon completion of the study.</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-align: justify;">  </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">In 2011, three consultants of the Company exercised 462,128 options for $31.</p>
<p style="margin: 0px 0px 0px 2in; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">A summary of the Company's stock awards activity related to shares issued to service providers and related information is as follows:</font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="width: 60%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">Year ended <br />December 31,</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">Year ended <br />December 31,</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">2011</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">2010</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Amount <br />of shares</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Weighted<br />average <br />issue <br />price</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Amount <br />of shares</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Weighted<br />average<br />issue <br />price</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="text-align: center;" colspan="2"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">$</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="text-align: center;" colspan="2"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: center;" colspan="2">$</td>
<td style="padding-bottom: 1pt;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-left: 5.65pt; width: 48%; text-indent: -5.65pt; text-align: left;">Outstanding at beginning of period</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">9,735,508</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">0.25</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">8,225,508</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 10%; text-align: right;">0.26</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">Issued</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,265,870</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.41</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,510,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.20</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">Outstanding at end of period</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">11,001,378</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.27</td>
<td style="text-align: left;"></td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">9,735,508</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.25</td>
<td style="text-align: left;"> </td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0px; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">c)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">Stock-based compensation and issuance of shares recorded by the Company in respect of shares and warrants granted to service providers amounted to $449 and $96 for the year ended December 31, 2011 and 2010, respectively. </font></td>
</tr>
</table>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The total stock-based compensation expense, related to shares, options and warrants granted to employees and service providers, was comprised, at each period, as follows: </font></p>
<p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p>
<table style="width: 60%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" border="0" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">Year ended<br />December 31,</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;">Period from <br />September 22, <br />2000 (inception<br />date) through <br />December 31,</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;">2011</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="9">U.S. $ in thousands</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: center;"> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 43%; text-align: left;">Research and development</td>
<td style="width: 1%;"></td>
<td style="width: 1%; text-align: left;">$</td>
<td style="width: 15%; text-align: right;">316</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;">$</td>
<td style="width: 15%; text-align: right;">325</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;">$</td>
<td style="width: 20%; text-align: right;">17,556</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">General and administrative</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,075</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">560</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: right;">10<font style="font: 10pt/110% times new roman, times, serif;">,113</font></td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="padding-bottom: 1pt; text-align: left;">Financial expenses, net</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">192</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">-</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">248</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-bottom: 2.5pt; text-align: left;">Total stock-based compensation expense</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;">$</td>
<td style="border-bottom: black 2.5pt double; text-align: right;">1,584</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;">$</td>
<td style="border-bottom: black 2.5pt double; text-align: right;">885</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;">$</td>
<td style="border-bottom: black 2.5pt double; text-align: right;">27,917</td>
</tr>
</table>
<table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 8   -</td>
<td style="text-align: justify;">STOCK CAPITAL</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 27.75pt;">A.</td>
<td style="text-align: justify;">The rights of Common Stock are as follows:</td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;">Holders of Common Stock have the right to receive notice to participate and vote in general meetings of the Company, the right to a share in the excess of assets upon liquidation of the Company and the right to receive dividends, if declared.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;">The Common Stock is registered and publicly traded on the Over-the-Counter Bulletin Board service of the National Association of Securities Dealers, Inc. under the symbol BCLI.</p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0; text-align: justify; text-indent: 0in;">  </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 56.7pt;"></td>
<td style="width: 28.35pt;">B.</td>
<td style="text-align: justify;">Issuance of shares warrants and options:</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">1.</td>
<td style="text-align: justify;">Private placements:</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">a)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On June 24, 2004, the Company issued to investors 8,510,000 shares of Common Stock for total proceeds of $60 (net of $25 issuance expenses).</font></td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">b)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On February 23, 2005, the Company completed a private placement for sale of 1,894,808 units for total proceeds of $1,418. Each unit consists of one share of Common Stock and a three-year warrant to purchase one share of Common Stock at $2.50 per share. This private placement was consummated in three tranches which closed in October 2004, November 2004 and February 2005.</font></td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">c)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On May 12, 2005, the Company issued to an investor 186,875 shares of Common Stock at a price of $0.8 per share for total proceeds of $149.</font></td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">d)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 27, 2005, the Company issued to investors 165,000 shares of Common Stock at a price of $0.6 per share for total proceeds of $99.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">e)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On August 11, 2005, the Company signed a private placement agreement with investors for the sale of up to 1,250,000 units at a price of $0.8 per unit. Each unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock at $1.00 per share. The warrants are exercisable for a period of three years from issuance. On March 31, 2005, the Company sold 312,500 units for total net proceeds of $225. On December 7, 2005, the Company sold 187,500 units for total net proceeds of $135.</font></td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">f)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On July 2, 2007, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to 27,500,000 shares of
Common Stock, for an aggregate subscription price of up to $5 million and warrants to purchase up to 30,250,000 shares of Common Stock. Separate closings of the purchase and sale of the shares and the warrants were originally scheduled to take place as follows:</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 170.1pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="font-weight: bold; text-align: left; border-bottom: black 1pt solid; padding-left: 0; text-indent: 0;">Purchase date</td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Purchase price</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number of <br />subscription <br />shares</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number of <br />warrant <br />shares</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: left; padding-left: 0; text-indent: 0;"> </td>
<td> </td>
<td style="text-align: right;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: right;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: right;" colspan="2"> </td>
<td> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 41%; text-align: left; text-indent: 0; padding-left: 0; vertical-align: top;">August 30, 2007</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left; vertical-align: top;">$</td>
<td style="width: 20%; text-align: center;">1,250 (includes $250 paid as a convertible loan)</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 15%; text-align: right;">6,875,000</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 15%; text-align: right;">7,562,500</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; text-indent: 0; padding-left: 0;">November 15, 2007</td>
<td> </td>
<td style="text-align: left;">$</td>
<td style="text-align: right;">750</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left; text-indent: 0; padding-left: 0;">February 15, 2008</td>
<td> </td>
<td style="text-align: left;">$</td>
<td style="text-align: right;">750</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; text-indent: 0; padding-left: 0;">May 15, 2008</td>
<td> </td>
<td style="text-align: left;">$</td>
<td style="text-align: right;">750</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left; text-indent: 0; padding-left: 0;">July 30, 2008</td>
<td> </td>
<td style="text-align: left;">$</td>
<td style="text-align: right;">750</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; text-indent: 0; padding-left: 0;">November 15, 2008</td>
<td> </td>
<td style="text-align: left;">$</td>
<td style="text-align: right;">750</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 18, 2009, the Company entered into an amendment to the investment agreement with the investor providing for the following:</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(a)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The investor shall invest the remaining amount of the original investment agreement at price per share of $0.12 in monthly installments of not less than $50 starting August 1, 2009. The investor may accelerate such payments at his discretion.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;
text-indent: 0in;"><font style="font-weight: normal;"> </font>  </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">1.</td>
<td style="text-align: justify;">Private placements: (Cont.)</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 133.65pt; text-align: justify; text-indent: -0.25in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(b)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The exercise price of the last 10,083,334 warrants decreased from an exercise price of $0.36 per share to $0.29 per share. </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(c)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">All warrants expire on November 5, 2013 instead of November 5, 2011.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(d)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The price per share of the investment agreement decreased from $0.1818 to $0.12, therefore the Company adjusted the number of Shares of Common Stock issuable pursuant the investment agreement retroactively and issued to the investor on October 28, 2009 an additional 9,916,667 shares of Common Stock for past investment.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;"><font style="font-weight: normal;">(e)</font></td>
<td style="text-align: justify;"><font style="font-weight: normal;">The investor has the right to cease payments in the event that the price per share as of the closing on five consecutive trading days shall decrease to $0.05.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On January 18, 2011 the Company and an investor signed an agreement to balance amounts due to the investor, totaling $20, against the remaining balance of the investment. The Company issued to the investor 10,499,999 shares of Common Stock and a warrant to purchase 4,539,500 shares of the Company's Common Stock at an exercise price of $0.20 per share</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">As of March 31, 2011, the Company issued to the investor and its designees an aggregate of 41,666,667 shares of common stock and a warrant to purchase 10,083,333 shares of the Company's common stock at an exercise price of $0.20 per share and a warrant to purchase 20,166,667 shares of common stock at an exercise price of $0.29 per share. The warrants may be exercised at any time and expire on November 5, 2013. </font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In addition, the Company agreed to issue an aggregate of 1,250,000 shares of Common Stock to a related party as an introduction fee for the investment. The shares shall be issued pro rata to the funds received from the investor.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">As of December 31, 2010, the introduction fee was paid in full.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 115.65pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">g)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">In January 2010, the Company issued 1,250,000 units to a private investor for total proceeds of $250. Each unit consists of one share of Common Stock and a two-year warrant to purchase one share of Common Stock at $0.50 per share. </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">h)</td>
<td style="text-align: justify;"><font style="font: normal 10pt times new roman, times, serif; font-variant:
normal;">In February 2010, the Company issued 6,000,000 shares of Common Stock to 3 investors (2,000,000 to each investor) and warrants to purchase an aggregate of 3,000,000 shares of Common Stock (1,000,000 to each investor) with an exercise price of $0.5 for aggregate proceeds of $1,500 ($500 each).</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">i)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On February 7, 2011, the Company issued 833,333 shares of Common Stock, at a price of $0.3 per share, and a warrant to purchase 641,026 shares of the Company's Common Stock at an exercise price of $0.39 per share for one year for total proceeds of $250.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt;"><font style="font-weight: normal;"> </font>  </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">1.</td>
<td style="text-align: justify;">Private placements: (Cont.)<font style="font-weight: normal;"> </font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 2.25in; text-align: justify; text-indent: -0.25in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">j)</td>
<td style="text-align: justify;"><font style="font-weight: normal;">On February 23, 2011, the Company entered into an investment agreement, pursuant to which the Company agreed to sell up to 12,815,000 shares of Common Stock, for an aggregate subscription price of up to $3.6 million and warrants to purchase up to 19,222,500 shares of Common Stock as follows: warrant to purchase 12,815,000 shares of Common Stock at $0.5 for two years, and warrants to purchase 6,407,500 shares of Common Stock at $0.28 for one year.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In addition, the Company agreed to pay 10% of the funds received for the distribution services received, out of this amount, 4% was be paid in stock and the remaining 6% in cash. Accordingly, in March 2011, the company issued 512,600 Common Stock and paid $231.</font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0.5in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">2.</td>
<td style="text-align: justify;">Share-based compensation to employees and to directors:</td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">a)</td>
<td style="text-align: justify;">Options to employees and directors:</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On November 25, 2004, the Company's stockholders approved the 2004 Global Stock Option Plan and the Israeli Appendix thereto (which applies solely to participants who are residents of Israel) and on March 28, 2005, the Company's stockholders approved the 2005 U.S. Stock Option and Incentive Plan, and the reservation of 9,143,462 shares of Common Stock for issuance in the aggregate under these stock option plans.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">Each option granted under the plans is exercisable until the earlier of ten years from the date of grant of the option or the expiration dates of the respective option plans. The 2004 and 2005 options plans will expire on November 25, 2014 and March 28, 2015, respectively. The exercise price of the options granted under the plans may not be less than the nominal value of the shares into which such options are exercised. The options vest primarily over three or four years. Any options that are canceled or forfeited before expiration become available for future grants.</font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0.5in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 5, 2008, the Company's stockholders approved an amendment and restatement of the Company’s 2004 Global Share Option Plan and 2005 U.S. Stock Option and Incentive Plan to increase the number of shares of common stock available for issuance under these stock option plans in the aggregate by 5,000,000 shares.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In June 2011, the Company's stockholders approved an increase the number of shares of common stock available for issuance under these stock option plans in the aggregate by 5,000,000 shares.</font></p>
<p style="font: 10pt
times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">As of March 31, 2012, 1,825,103 options are available for future grants.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 27, 2005, the Company granted one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.75 per share. The option is fully vested and expires after 10 years.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On February 6, 2006, the Company entered into an amendment to the Company's option agreement with the Company's former Chief Financial Officer. The amendment changed the exercise price of the 400,000 options granted to him on February 13, 2005 from $0.75 to $0.15 per share. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font> <font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 2, 2006, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and expires after 10 years. The compensation related to the option, in the amount of $48, was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 22, 2006, the Company entered into an amendment to the Company's option agreement with two of its employees. The amendment changed the exercise price of 270,000 options granted to them from $0.75 to $0.15 per share. The excess of the fair value resulting from the modification, in the amount of $2, was recorded as general and administration expense over the remaining vesting period of the options.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On September 17, 2006, the Company entered into an amendment to the Company's option agreement with one of its directors. The amendment changed the exercise price of 100,000 options granted to the director from $0.75 to $0.15 per share.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On March 21, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $43, was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On July 1, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $38, was recorded as general and administrative expense. On October 22, 2007, the Company and the director agreed to cancel and relinquish all the options which were granted on July 1, 2007.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On July 16, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $75, was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 27, 2007, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $84, was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On October 23, 2007, the Company granted to its Chief Executive Officer an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.87 per share. The option is fully vested and expires after 10
years. The total compensation related to the option is $733, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0.5in;">   <font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On November 5, 2008, the Company entered into an amendment to the Company's option agreement with the Company's Chief Executive Officer. The amendment changed the exercise price of the 1,000,000 options from $0.87 to $0.15 per share. The compensation related the modification of the purchase price in the amount of $4 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 29, 2009, the Company granted to its former Chief Executive Officer and director an option to purchase 1,000,000 shares of Common Stock at an exercise price of $0.067 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $68, which is amortized over the vesting period as general and administrative expense. In February 2011, the former CEO resigned. On July 25, 2011 the Company signed a settlement agreement with the former CEO under which 483,333 shares out of the above grant became fully vested exercisable through April 30 2012. An additional $30 was written as compensation in general and administrative expense. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">After the balance sheet date, the former CEO exercised the option to 483,333 shares of Common Stock for an exercise price of $32.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-family: times new roman, times, serif; font-weight: normal;">On June 29, 2009, the Company granted to its former Chief Financial Officer an option to purchase 200,000 shares of Common Stock at an exercise price of $0.067 per share. The option vested with respect to 1/3 of the shares subject to the option. In connection with the former Chief Financial Officer’s resignation,</font> <font style="font-family: times new roman, times, serif;">2/3 of the above shares were cancelled and the remaining 66,667 are valid through April 7, 2011.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 31, 2009, the Company granted to two of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. Each option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $32, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On December 13, 2009, the Company granted to one of its directors an option to purchase 100,000 shares of Common Stock at an exercise price of $0.15 per share. The option is fully vested and is exercisable for a period of 10 years. The compensation related to the option, in the amount of $21, was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On February 10, 2010, the Company granted to an employee an option to purchase 30,000 shares of Common Stock at an exercise price of $0.32 per share. The option vests with respect to 1/3 of the shares subject to the option on each anniversary of the date of grant and expires after 10 years. The total compensation related to the option is $9, which is amortized over the vesting period as research and development expense. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">   <font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 13, 2010, the Company, Abraham Israeli and Hadasit Medical Research Services and Development Ltd. (“Hadasit”) entered into an Agreement (the “Agreement”) pursuant to which Mr. Israeli agreed, during the term of the Agreement, to serve as (i) the Company’s Clinical Trials Advisor and (ii) a member of the Company’s Board of Directors.  In consideration of the services to be provided by Mr. Israeli to the Company under the Agreement, the Company agreed to grant options annually during the term of the Agreement for the purchase of its Common Stock, as follows:</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 0.25in;"><font style="font-family: symbol; font-weight:
normal;">·</font></td>
<td style="text-align: justify;"><font style="font-family: times new roman, times, serif; font-weight: normal;">An option for the purchase of 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share to Mr. Israeli; and</font></td>
</tr>
</table>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 141.75pt;"></td>
<td style="width: 0.25in;"><font style="font-family: symbol; font-weight: normal;">·</font></td>
<td style="text-align: justify;"><font style="font-family: times new roman, times, serif; font-weight: normal;">An option for the purchase of 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share to Hadasit,</font></td>
</tr>
</table>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 141.75pt;"></td>
<td style="width: 0.25in; text-align: left;"><font style="font-family: symbol; font-weight: normal;">·</font></td>
<td style="text-align: justify;"><font style="font-family: times new roman, times, serif;">*    Such options will vest and become exercisable in twelve (12) consecutive equal monthly amounts.</font></td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In April 2010, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option was $50, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On January 30, 2011 the Company signed an agreement with a new COO and acting CEO. According to the employment agreement, the new COO received 450,000 options to purchase Common Stock of the Company at $0.20.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 27 2011, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. The total compensation related to the option was $48, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 27 2011, the Company granted to four of its directors an option to purchase 634,999 shares of Common Stock of the Company at $0.15. The total compensation related to the option was $287, which is amortized over the vesting period as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 10 2011, the Company granted to its CEO, an option to purchase 70,000 shares of Common Stock of the Company at $0.20. The total compensation related to the option was $26, which was amortized as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;">In the three months ended March 31 2012, 167,849 options were exercised by former CEO of the Company for $20.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify;">After the balance sheet date, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0; text-align: left;">   </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.35pt;">b)</td>
<td style="text-align: justify;">Restricted shares to directors (Cont.):</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">A summary of the Company's option activity related to options to employees and directors, and related information is as follows:</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="10">For the period ended <br />March 31, 2012</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Amount <br />of <br />options</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
<td style="font-weight: bold; padding-bottom:
1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Weighted <br />average <br />exercise <br />price</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Aggregate <br />intrinsic <br />value</td>
<td style="padding-bottom: 1pt; font-weight: bold;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt; text-align: right;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; font-weight: bold; text-align: center;"> </td>
<td style="border-bottom: black 1pt solid; font-weight: bold; text-align: center;">$</td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left;"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; font-weight: bold; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; font-weight: bold; text-align: center;">$</td>
<td style="padding-bottom: 1pt; font-weight: bold; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 41%; text-align: left;">Outstanding at beginning of period</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 20%; text-align: right;">4,938,821</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 15%; text-align: right;">0.168</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 15%; text-align: right;"> </td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">Granted</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">Exercised</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">167,849</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.150</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 1pt;">Reclassified</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">13,784</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt; text-align: right;">0.067</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt; text-align: right;"> </td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 2.5pt;">Outstanding at end of period</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">4,784,756</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">0.169</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">807,430</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 2.5pt;">Vested and expected-to-vest at end of period</td>
<td style="padding-bottom:
2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">3,784,617</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">0.166</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">627,162</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 2, 2006, the Company issued to two of its directors 200,000 restricted shares of common stock (100,000 each). The restrictions on the shares have fully lapsed. The compensation related to the stocks issued amounted to $104, which was amortized over the vesting period as general and administrative expenses.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to a director 100,000 restricted shares of Common Stock. The restrictions on the shares have fully lapsed. The compensation related to the shares issued amounted to $47, which was amortized over the vesting period as general and administrative expenses.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In addition, on April 20, 2007, based on a board resolution dated March 21, 2007, the Company issued to another director 100,000 restricted shares of Common Stock. The restricted shares are not subject to any right to repurchase, and the compensation related to the shares issued amounted to $47 was recorded as prepaid general and administrative expenses in the three months ended March 31, 2007.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 27, 2008, the Company issued to one of its directors 960,000 shares of Common Stock upon a cashless exercise by a shareholder of a warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $.01 per share that was acquired by the shareholder from Ramot. The shares were allocated to the director by the shareholder.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font>  <font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In May 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its directors 300,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In May and in June 2010, based on a board resolution dated June 29, 2009, the Company issued to three of its Scientific Advisory Board members and two of its Advisory Board members 500,000 restricted shares of common stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 6, 2010, Prof. Melamed fully exercised his warrant to purchase 1,097,215 shares of the Company’s Common Stock; the warrant was issued to him pursuant to the agreement with the Consultants effective as of November 4, 2004. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 85.05pt;"></td>
<td style="width: 28.35pt;">3.</td>
<td style="text-align: justify;">Shares and warrants to investors and service providers:</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">The Company accounts for shares and warrants issued to non-employees using the guidance of ASC 718-10 (formerly "SFAS" 123(R)), "Accounting for Stock-Based Compensation" and ASC 505-50-30 (formerly "EITF" 96-18), "Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling, Goods or Services," whereby the fair value of such option and warrant grants is determined using a Black-Scholes options pricing model at the earlier of the date at which the non-employee's performance is completed or a performance commitment is reached.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt;
text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font><font style="font-weight: normal;"> </font> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 0;"></td>
<td style="width: 28.35pt;"><b>a)</b></td>
<td style="text-align: justify;"><b>Warrants to investors and service providers and investors: </b></td>
</tr>
</table>
<table style="width: 100%; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="font-weight: bold; text-align: left; border-bottom: black 1pt solid;" nowrap="nowrap">Issuance date</td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Number of <br />warrants <br />issued</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Exercised</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Forfeited</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Outstanding</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Exercise <br />Price $</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Warrants <br />exercisable</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Exercisable through</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: center;" colspan="2"> </td>
<td> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 37%; text-align: left;">November 2004</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">12,800,845</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">11,761,281</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">151,803</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">887,761</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">0.01</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">887,761</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 6%; text-align: right;">April 2012</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">December 2004</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,800,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,800,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">–</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,894,808</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,894,808</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2.5</td>
<td
style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">47,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">47,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1.62</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">June 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">June 2015</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">August 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">70,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">70,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">September 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">September 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">36,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">36,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">September-December 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom;
background-color: white;">
<td style="text-align: left;">December 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">20,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">20,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">December 2005</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">457,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">150,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">307,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">307,163</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">December 2015</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.65</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">230,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2016</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">40,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">40,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">8,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">189,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">97,696</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">91,304</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0. 5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td
style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.0005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">May 2016</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May -December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.35</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May -December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">48,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.75</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">May 2011</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">June 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">24,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">24,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">May 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">19,355</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">19,355</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">630,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">630,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td
style="text-align: left;"> </td>
<td style="text-align: right;">0.3</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">December 2006</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.47</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.47</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">March 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">15,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">15,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td
style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">225,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">225,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">March 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">50,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,300</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,300</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">May 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.39</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">July 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">September 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">August 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">August 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align:
left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.2</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">7,562,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">30,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">July 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.45</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;" nowrap="nowrap">August-October 2017</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">November 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.20</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,520,833</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">November 2007</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">2,016,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align:
left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">August 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,529,166</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">August 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,008,333</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">November 2008</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.15</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">September 2018</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.1</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2019</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">October 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">200,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">100,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.067</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">66,667</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">October 2019</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">October 2009</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td
style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">January 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,250,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">125,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.01</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">3,000,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">January 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.29</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">4,537,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">November 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">641,026</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">641,026</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.39</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">6,407,500</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">946,834</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">5,460,666</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.28</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-</td>
<td
style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">February 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.5</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">12,815,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2013</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">April 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">0.00005</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2020</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">April 2011</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">33,334</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">April 2021</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left;">February 2010</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">1,500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;"> </td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">500,000</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">February 2020</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">78,604,165</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">15,633,811</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">14,533,762</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">48,436,590</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt; text-align: right;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">47,403,257</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt; text-align: right;"> </td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
</tr>
</table>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0; text-align: justify; text-indent: 0in;"> <font style="font-weight: normal;"> </font><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">The fair value for the warrants to service providers was estimated on the date of grant
using a Black-Scholes option pricing model, with the following weighted-average assumptions for the 3 month activity ended on March 31, 2011; weighted average volatility of 134%-141%, risk free interest rates of 2.26%-3.47% dividend yields of 0% and a weighted average life of the options of 6-10 years. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: 0in;"> </p>
<table style="margin-top: 0pt; width: 100%; font: bold 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 113.4pt;"></td>
<td style="width: 28.5pt;">b)</td>
<td style="text-align: justify;">Shares:</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 1 and June 4, 2004, the Company issued 40,000 and 150,000 shares of Common Stock for 12 months of filing services and legal and due-diligence services, respectively, with respect to a private placement. Compensation expense related to filing services, totaling $26, was amortized over a 12-month period. Compensation related to legal services, totaling $105 was recorded as equity issuance cost and had no effect on the statement of operations.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On July 1 and September 22, 2004, the Company issued 20,000 and 15,000 shares to a former director for financial services for the first and second quarters of 2004, respectively. Related compensation in the amount of $39 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On February 10, 2005, the Company signed an agreement with one of its service providers under which the Company issued the service provider 100,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In March and April 2005, the Company signed an agreement with four members of its Scientific Advisory Board under which the Company issued to the members of the Scientific Advisory Board 400,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan (100,000 each). All restrictions on these shares have lapsed.</font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In July 2005, the Company issued to its legal advisors 50,000 shares for legal services for 12 months. The compensation related to the shares in the amount of $37.5 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">In January 2006, the Company issued to two service providers 350,000 restricted shares at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. All restrictions on these shares have lapsed. Related compensation in the amount of $23 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On March 6, 2006, the Company issued to its legal advisor 34,904 shares of Common Stock. The shares are in lieu of $18.5 payable to the legal advisor. Related compensation in the amount of $18.5 was recorded as general and administrative expense. </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 13, 2006, the Company issued to service providers 60,000 shares of Common Stock at a purchase price of $0.00005 par value under the U.S. Stock Option and Incentive Plan of the Company. Related compensation in the amount of $25.8 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">  </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 9, 2006, the Company issued to its legal advisor 65,374 shares of Common Stock in lieu of payment for legal services. Related compensation in the amount of $33 was recorded as general and administrative expense.</font></p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0; text-align: justify; text-indent: 0in;"> <font style="font-weight: normal;"> </font><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On June 7, 2006, the Company issued to a service provider 50,000 shares of Common Stock for filing services for 12 months. Related compensation in the amount of $24.5 was recorded as general and administrative expense.
</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 5, 2006, the Company issued 200,000 shares of Common Stock to a finance consultant for his services. Related compensation in the amount of $102 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 14, 2006, the Company issued 200,000 shares of Common Stock to a service provider. Related compensation in the amount of $68 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On August 17, 2006, the Company issued 100,000 shares of Common Stock to a service provider. Related compensation in the amount of $35 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On September 17, 2006, the Company issued to its legal advisor 231,851 shares of Common Stock in lieu of $63 payable to the legal advisor. [Related compensation in the amount of $63 was recorded as general and administrative expense.]</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 1 and September 30, 2006, the Company issued to its business development advisor, based on an agreement, 240,000 shares of Common Stock. Related compensation in the amount of $74 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On January 3, 2007, the Company issued to its legal advisor 176,327 shares of Common Stock in lieu of $45 payable to the legal advisor. Related compensation in the amount of $49 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 12, 2007, the Company issued to its filing and printing service providers 80,000 shares of Common Stock in lieu of $15 payable to the service provider. Related compensation in the amount of $30 was recorded as general and administrative expense. In addition, the Company was obligated to issue the filing and printing service providers additional shares, in the event that the total value of the shares previously issued (as quoted on the Over-the-Counter Bulletin Board or such other exchange where the Common Stock is quoted or listed) was less than $0.20 on March 20, 2008. As a result, the Company recorded a liability in the amount of $20.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On April 12, 2007, the Company issued to its legal advisor 108,511 shares of Common Stock in lieu of $29 payable to the legal advisor. Related compensation in the amount of $40 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On May 18, 2007, the Company issued to its legal advisor 99,257 shares of Common Stock in lieu of $33 payable to the legal advisor. Related compensation in the amount of $33 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">   </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On October 29, 2007, the Company issued to a scientific advisory board member 80,000 shares of the Company’s Common Stock for scientific services. Compensation of $67 was recorded as research and development expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On May 20, 2008, the Company issued to its financial advisor 90,000 shares of the Company's Common Stock. The shares were for $35 payable to the financial advisor for introduction fee of past convertible loans. Related compensation in the amount of $36 was recorded as financial expenses.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On April 5, 2009, the Company issued to its Chief Technology Advisor 1,800,000 shares of Common Stock. The shares were for $180 payable to the advisor. Related compensation in the amount of $144 was recorded as
research and development expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On June 24, 2009, the Company issued to its public relations advisor 250,000 shares of Common Stock. The shares were for $25 payable to the advisor. Related compensation in the amount of $18 was recorded as general and administrative expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On July 8, 2009, the Company issued to its financial consultant 285,714 shares of the Company's Common Stock. The shares were for $20 payable to the financial consultant for valuation of options and warrants. Related compensation in the amount of $20 was recorded as general and administrative expense.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On July 15, 2009, the Company issued to a service provider 357,142 shares of the Company's Common Stock. The shares were for $25 payable to the service provider for filing services. Related compensation in the amount of $21 was recorded as general and administrative expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On August 10, 2009, the Company issued to a service provider 71,428 shares of the Company's Common Stock. The shares were for $5 payable to the service provider for IT services. Related compensation in the amount of $4 was recorded as general and administrative expense.</p>
<p style="font: bold 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On January 5, 2010, the Company issued to its public relations advisor 50,000 shares of the Company's Common Stock for six months service. The issuance of the shares is part of the agreement with the public relations advisor that entitled them to a monthly grant of 8,333 shares of the Company's Common Stock. Related compensation in the amount of $12 was recorded as general and administrative expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 143pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On January 6, 2010, the Company issued to a service provider 60,000 shares of the Company's Common Stock. The shares were for $15 payable to the service provider for insurance and risk management consulting and agency services for three years. Related compensation in the amount of $16 was recorded as general and administrative expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On March 5, 2007, the Company issued a $150 Convertible Promissory Note to a third party. Interest on the note accrued at the rate of 8% per annum for the first year and 10% per annum after the first year. On January 27, 2010, the third party converted the entire accrued principle and interest outstanding under the note, amounting to $189, into 1,016,109 shares of Common Stock.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On December 13, 2009, the Company issued a $135 Convertible Promissory Note to it legal advisor for $217 in legal fees accrued through October 31, 2009. Interest on the note accrued at the rate of 4%. On February 19, 2010, the Company’s legal advisor converted the entire accrued principal and interest of outstanding under the note into 402,385 shares of Common Stock.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0.5in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">In May 2010, based on a board resolution dated June 29, 2009 the Company issued to one of its public relations advisors 100,000 restricted shares of Common Stock. The restrictions of the shares shall lapse in three annual and equal portions commencing with the grant date.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 143pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On December 16, 2010, the Company issued to a service provider 83,333 shares of the Company's Common Stock. The shares were for public relations services. Related compensation in the amount of $40 is recorded as general and administrative expense.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On December 16, 2010, the Company granted to its Chief Medical Advisor 900,000 shares of the Company's Common Stock for services rendered through December 31 2010. Related compensation in the amount of $180 is recorded as research and development expense (see Note 5B).</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On December 16, 2010 the Company granted to its Chief Scientist 200,000 shares of the Company's Common Stock for services rendered through December 31 2010. Related compensation in the amount of $40 is recorded as research and development expense (see Note 5B).</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent:
0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;">On February 16, 2011 one of the Company's consultants exercised 100,000 warrants to Common Stock for $33.</font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"><font style="font-weight: normal;"> </font></p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">On February 18, 2011, the Company's legal advisor converted the entire accrued principal and interest of the Convertible Promissory Note granted on September 15, 2010, totaling $137, into 445,617 shares of Common Stock.</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;">The total stock-based compensation expense, related to shares, options and warrants granted to employee’s directors and service providers, was comprised, at each period, as follows:</p>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 141.75pt; text-align: justify; text-indent: 0in;"> </p>
<table style="width: 70%; font: 10pt times new roman, times, serif; margin-left: 141.75pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: bottom;">
<td style="font-weight: normal; text-align: left;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6" nowrap="nowrap">Three months <br />ended March 31</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Period from <br />September 22, 2000 <br />(inception date)<br />through<br />March 31,</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-weight: normal; text-align: left;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">2012</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">2011</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">2012</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-weight: normal; text-align: left;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6" nowrap="nowrap">Unaudited</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
<td style="font-weight: bold; padding-bottom: 1pt;" nowrap="nowrap"> </td>
<td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Unaudited</td>
<td style="padding-bottom: 1pt; font-weight: bold;" nowrap="nowrap"> </td>
</tr>
<tr style="vertical-align: bottom;">
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: right;" colspan="2"> </td>
<td> </td>
<td> </td>
<td style="text-align: right;" colspan="2"> </td>
<td> </td>
<td style="font-weight: normal;"> </td>
<td style="font-weight: normal; text-align: right;" colspan="2"> </td>
<td style="font-weight: normal;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="width: 55%; text-align: left;">Research and development</td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;">13</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;">9</td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 1%;"> </td>
<td style="width: 1%; text-align: left;"> </td>
<td style="width: 12%; text-align: right;">17,556</td>
<td style="width: 1%; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left;">General and administrative</td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">168</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">-2</td>
<td style="text-align: left;"> </td>
<td> </td>
<td style="text-align: left;"> </td>
<td style="text-align: right;">10,281</td>
<td style="text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: #ccffcc;">
<td style="text-align: left; padding-bottom: 1pt;">Financial expenses, net</td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">-</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">-</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
<td style="padding-bottom: 1pt;"> </td>
<td style="border-bottom: black 1pt solid; text-align: left;"> </td>
<td style="border-bottom: black 1pt solid; text-align: right;">248</td>
<td style="padding-bottom: 1pt; text-align: left;"> </td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-align: left; padding-bottom: 2.5pt; text-indent: -5.65pt; padding-left: 5.65pt;">Total stock-based compensation expense</td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double;
text-align: right;">181</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">7</td>
<td style="padding-bottom: 2.5pt; text-align: left;"> </td>
<td style="padding-bottom: 2.5pt;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: left;"> </td>
<td style="border-bottom: black 2.5pt double; text-align: right;">28,098</td>
</tr>
</table>
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.15pt;">NOTE 15 -</td><td style="text-align: justify;">SUBSEQUENT EVENTS</td></tr></table><p style="margin: 0px 0px 0px 1.55in; font: 10pt times new roman, times, serif; text-indent: -26.55pt; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>A.</b></td><td style="text-align: justify;">In January 2012, one of the Company’s service providers exercised a warrant for 125,000 shares of Common Stock of the Company.</td></tr></table><p style="margin: 0px 0px 0px 76.5pt; font: 10pt times new roman, times, serif; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>B.</b></td><td style="text-align: justify;">On February 3, 2012, the Company filed an S-1 Registration Statement with the Securities and Exchange Commission.</td></tr></table><p style="margin: 0px; font: 10pt/110% times new roman, times, serif; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"> </td><td style="width: 28.35pt; text-align: justify;"><b>C.</b></td><td style="text-align: justify;"><font style="font: 10pt/110% times new roman, times, serif; color: black;">In February 2012, the former CEO exercised options to purchase 132,038 shares of Common Stock.</font></td></tr></table><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top; text-align: justify;">
<td style="width: 56.7pt; text-align: left;">NOTE 9   -</td>
<td style="text-align: justify;">SUBSEQUENT EVENTS</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 56.7pt; text-align: justify;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 58.5pt;"></td>
<td style="width: 27pt;"><b>A.</b></td>
<td style="text-align: justify;">In April 2012, the former CEO exercised 1,014,757 options to shares of Common Stock of the Company. An exercise fee of $112 was paid to the Company. (See note 8 B 2 (a))</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0 0pt 85.5pt; text-align: justify;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 58.5pt;"></td>
<td style="width: 27pt;"><b>B.</b></td>
<td style="text-align: justify;">In April 2012, the Company granted to Mr. Israeli an option to purchase 166,666 shares of Common Stock at an exercise price equal to $0.00005 per share. (See note 8 B 2 (a))</td>
</tr>
</table>
<p style="font: 10pt times new roman, times, serif; margin: 0pt 0.5in 0pt 0; text-align: justify;"> </p>
<table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0">
<tr style="vertical-align: top;">
<td style="width: 58.5pt;"></td>
<td style="width: 27pt;"><b>C.</b></td>
<td style="text-align: justify;">In April 2012, the Company granted to Hadasit a warrant to purchase 33,334 shares of Common Stock at an exercise price equal to $0.00005 per share. (See note 8 B 2 (a))</td>
</tr>
</table>
<table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.9pt;">NOTE 5 -</td><td style="text-align: justify;">ACCOUNTS RECEIVABLE</td></tr></table><p style="margin: 0px; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> <font style="font-weight: normal;"> </font></p><table align="right" style="font: 10pt times new roman, times, serif; width: 88%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">December 31,</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 0px; width: 74%; text-align: left;">Government authorities</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">76</td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">36</td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 0px; padding-bottom: 1pt; text-align: left;">Grants receivable from the CSO</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">236</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">391</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.4pt; padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">312</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">427</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.9pt;">NOTE 6 -</td><td style="text-align: justify;">PROPERTY AND EQUIPMENT</td></tr></table><p style="margin: 0px; font: bold 10pt/11pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table align="right" style="font: 10pt times new roman, times, serif; width: 88%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">December 31,</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="text-align: left;">Cost:</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 5.65pt; width: 74%; text-align: left;">Office furniture and equipment</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">9</td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">9</td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.65pt; text-align: left;">Computer software and electronic equipment</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">106</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">105</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 5.65pt; text-align: left;">Laboratory equipment</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">361</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">349</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.65pt; padding-bottom: 1pt; text-align: left;">Leasehold improvements</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">690</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">655</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt; text-align: right;">1,166</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt; text-align: right;">1,118</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="text-align: left;">Accumulated depreciation:</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 5.65pt; text-align: left;">Office furniture and equipment</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">4</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">3</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.65pt; text-align: left;">Computer software and electronic equipment</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">103</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">100</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 5.65pt; text-align: left;">Laboratory equipment</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">252</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">200</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.65pt; padding-bottom: 1pt; text-align: left;">Leasehold improvements</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">493</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">396</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">852</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">699</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="text-align: justify;"> </td><td style="font-size: 1pt;"> </td><td style="font-size: 1pt; text-align: left;"> </td><td style="font-size: 1pt; text-align: right;"> </td><td style="font-size: 1pt; text-align: left;"> </td><td style="font-size: 1pt;"> </td><td style="font-size: 1pt; text-align: left;"> </td><td style="font-size: 1pt; text-align: right;"> </td><td style="font-size: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 2.5pt; text-align: left;">Depreciated cost</td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">314</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">419</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><div> </div><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Depreciation expenses for the year ended December 31, 2011 and December 31, 2010 were $153, and $162, respectively. </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.9pt;">NOTE 7 -</td><td style="text-align: justify;">OTHER ACCOUNTS PAYABLE</td></tr></table><p style="margin: 0px; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">  </p><table align="right" style="font: 10pt times new roman, times, serif; width: 88%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">December 31,</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: left;"> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td><td> </td><td style="text-align: right;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 0px; width: 74%; text-align: left;">Employee and payroll accruals</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">141</td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">471</td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 0px; padding-bottom: 1pt; text-align: left;">Ramot accrued expenses</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">-</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">60</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.4pt; padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">141</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">531</td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/110% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.9pt;">NOTE 9 -</td><td style="text-align: justify;">SHORT-TERM CONVERTIBLE LOANS</td></tr></table><p style="margin: 0px; font: bold 10pt/110% times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;">On March 5, 2007, the Company issued a $150 Convertible Promissory Note to a third party. Interest on the note accrues at the rate of 8% per annum for the first year and 10% per annum afterward. The note will become immediately due and payable upon the occurrence of certain events of default, as defined in the note. The third party has the right at any time prior to the close of business on the maturity date to convert all or part of the outstanding principal and interest amount of the note into shares of Common Stock. The conversion price, as defined in the note, will be 75% (60% upon the occurrence of an event of default) of the average of the last bid and ask price of the Common Stock as quoted on the Over-the-Counter Bulletin Board for the five trading days prior to the Company's receipt of the third party written notice of election to convert, but in no event shall the conversion price be greater than $0.35 or more than 3,000,000 shares of Common Stock be issued. The conversion price will be adjusted in the event of a stock dividend, subdivision, combination or stock split of the outstanding shares. <font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;"><font style="font-weight: normal;">In addition, the Company granted to the third party warrants to purchase 150,000 shares of Common Stock at an exercise price of $0.45 per share. The warrants are fully vested and are exercisable at any time after March 5, 2007 until the second anniversary of the issue date. The fair value of the warrants is $43. </font></p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;"><font style="font-weight: normal; font-size: 10pt; line-height: 110%;">In accordance with</font><font style="font-weight: normal; font-size: 10pt; line-height: 110%;">ASC 470-20, the Company allocated the proceeds of the convertible note issued with detachable warrants based on the relative fair values of the two securities at the time of issuance. As a result, the Company recorded in its statement of changes in stockholders' equity for 2007 an amount of $22 with respect to the warrants and the convertible note was recorded in the amount of $128. </font></p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;"><font style="font-weight: normal;">The Company agreed to pay a finder's fee of $15; $13 was allocated to deferred charges and is amortized as financial expense over the note period and $2 was allocated to stockholder's equity. </font></p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;"><font style="font-weight: normal;">The Beneficial Conversion Feature in the amount of $122, embedded in the note was calculated based on a conversion rate of 60%, as defined upon the occurrence of an event of default and according to the notes’ effective conversion price. The amount was recorded as discount on the note against additional paid-in capital and is amortized to financial expense over the note period.</font> </p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;"><font style="font-weight: normal; font-size: 10pt;">On January 27, 2010, the third party converted the entire accrued principal and</font><font style="font-weight: normal; font-size: 10pt;">interest of the note, into 1,016,109 shares of Common Stock.</font> </p><p style="margin: 0px 0px 10pt 56.7pt; font: 10pt/115% times new roman, times, serif; text-align: justify;">In July 2011, the Company issued to the lender an additional 309,977 shares of Common Stock of the Company with regard to the above conversion.</p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt/11pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.9pt;">NOTE 10 -</td><td style="text-align: justify;">COMMITMENTS AND CONTINGENCIES</td></tr></table><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>A.</b></td><td style="text-align: justify;"><font style="font-weight: normal;">On December 1, 2004, BCT entered into a lease agreement for the lease of its facilities. The term of the lease was 36 months, with </font>two<font style="font-weight: normal;"> options to extend. Rent is paid on a quarterly basis in the amount of NIS 28,373 (approximately $8) per month.</font></td></tr></table><p style="margin: 0px 0px 0px 78pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 84.45pt; font: 10pt/110% times new roman, times, serif; text-indent: 0.6pt; text-align: justify;"><font style="font-weight: normal;">The facilities and vehicles of the Company and BCT are rented under operating leases that expire on various dates. Aggregate minimum rental commitments under non-cancelable leases as of December 31, 2011 are as follows:</font></p><p style="margin: 0px 0px 0px 78pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><table style="font: 10pt times new roman, times, serif; margin-left: 84.45pt; width: 80%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-weight: bold; text-align: left;">Period ending December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Facilities</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Vehicles</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Total</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="width: 40%; text-align: left;">2012</td><td style="width: 3%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 15%; text-align: right;">99</td><td style="width: 1%; text-align: left;"> </td><td style="width: 3%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 15%; text-align: right;">43</td><td style="width: 1%; text-align: left;"> </td><td style="width: 3%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 15%; text-align: right;">142</td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">2013</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">43</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">43</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-bottom: 1pt; text-align: left;">2014</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">-</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">22</td><td style="padding-bottom: 1pt; text-align: left;"> </td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">22</td><td style="padding-bottom: 1pt; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">99</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">109</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">207</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><p style="margin: 0px 0px 0px 78pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 84.45pt; font: 10pt/110% times new roman, times, serif; text-indent: 0.6pt; text-align: justify;">Total facilities rent expenses for the year ended December 31, 2011 and 2010 were $111 and $135 respectively.</p><p style="margin: 0px 0px 0px 78pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 74.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B.</td><td style="text-align: justify;"><font style="font-weight: normal;">On March 20, 2006, the Company entered into a Termination Agreement and General Release (the "Termination Agreement") with Dr. Yaffa Beck, the Company's former President and Chief Executive Officer who resigned her position as an officer and director of the Company on November 10, 2005.</font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 84.45pt; font: 10pt/110% times new roman, times, serif; text-indent: 0.6pt; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2011, there was still an unpaid balance of $17 to Dr. Beck under this Termination Agreement.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: bold 10pt/11pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">C.</td><td style="text-align: justify;"><font style="font-weight: normal;">Commitments to pay royalties to the Chief Scientist</font>: <font style="font-weight: normal;"></font></td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 84.45pt; font: 10pt/110% times new roman, times, serif; text-indent: 0.6pt; text-align: justify;"><font style="font-weight: normal;">BCT obtained from the Chief Scientist of the State of Israel grants for participation in research and development for the years 2007 through 2011, and, in return, BCT is obligated to pay royalties amounting to 3% of its future sales up to the amount of the grant. The grant is linked to the exchange rate of the dollar and bears interest of Libor per annum</font>.</p><p style="margin: 0px 0px 0px 113.4pt; font: bold 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;">Through December 31, 2011, total grants obtained amounted to $1,472</font>.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>D.</b></td><td style="text-align: justify;">On February 17, 2010, BCT entered into an agreement with Hadasit Medical Research Services and Development Ltd ("Hadasit") to conduct clinical trials in ALS patients. The agreement was revised in June 2011 according to which, in connection with the trials BCT will pay Hadasit $32,225 per patient totaling up to $773,400, as well as $64,915 per month for rental and operation of two clean rooms. The Company has the right to cease the rental of the clean rooms at any time upon 30 days prior notice.</td></tr></table><p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt/110% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;"><b>E.</b></td><td style="text-align: justify;">On April 17, 2008, Chapman, Spira & Carson, LLC (“CSC”) filed a breach of contract complaint in the Supreme Court of the State of New York (the “Court”) against the Company. The complaint alleges that CSC performed its obligations to the Company under a consulting agreement entered into between the parties and that the Company failed to provide CSC with the compensation outlined in the consulting agreement. The complaint seeks compensatory damages in an amount up to approximately $897, as well as costs and attorneys’ fees. On June 5, 2008, the Company filed an answer with the Court. The Company believes CSC’s claims are without merit and cannot predict what impact, if any, this matter may have on the business, its financial condition and results of operations and cash flow. Provision is included in the financial statements that Management believes is sufficient to address the risk.</td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.15pt;">NOTE 12 -</td><td style="text-align: justify;">RESEARCH AND DEVELOPMENT, NET</td></tr></table><table style="font: 10pt times new roman, times, serif; margin-left: 56.7pt; width: 80%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">Year ended<br />December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">Period from <br />September 22, <br />2000 (inception<br />date) through <br />December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="10">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="width: 61%; text-align: left;">Research and development</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">2,077</td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">1,385</td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">26,833</td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Less : Ramot reverse accruals (See Note 3)</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">(760</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 5.65pt; padding-bottom: 1pt; text-indent: -5.65pt; text-align: left;">Less : Participation by the Israeli Office of the Chief Scientist</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(388</td><td style="padding-bottom: 1pt; text-align: left;">)</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(340</td><td style="padding-bottom: 1pt; text-align: left;">)</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(1,654</td><td style="padding-bottom: 1pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: left;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">1,689</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">1,045</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">24,419</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.15pt;">NOTE 13 -</td><td style="text-align: justify;">TAXES ON INCOME</td></tr></table><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">A.</td><td style="text-align: justify;">Tax rates applicable to the income of the subsidiary:</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.1pt; text-align: justify;"> </p><p></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The corporate tax rate in Israel is as follows: 2008 - 27%, 2009 - 26%, 2010 - 25%, 2011 - 24%. In July 2009, the “Knesset” (Israeli parliament) passed the Economic Efficiency Law (Legislative Amendments for implementation of the economic plan for 2009 and 2010) of 2009 which defines, inter alia, further gradual reductions of corporate tax rates and real capital gains tax, in Israel, starting in 2011, to the following rates: 2012 - 23%, 2013 - 22%, 2014 - 21%, 2015 - 20% and in 2016 and onwards - 18%. Such tax reductions have no significant impact on the Company's financial statements<font style="font-family: times new roman, times, serif;">.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">In February 2008, the "Knesset" passed an amendment to the Income Tax (Inflationary Adjustments) Law, 1985, which limits the scope of the law beginning in 2008 and thereafter. Beginning in 2008, the results for tax purposes will be measured in nominal values, excluding certain adjustments for changes in the Consumer Price Index carried out in the period up to December 31, 2007. The amended law includes, inter alia, the elimination of the inflationary additions and deductions and the additional deduction for depreciation starting in 2008.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On September 26, 2011, the Social-Economic Reform Committee headed by Professor Manuel Trajtenberg published a report with its recommendations. Consequently, on December 6, 2011, the Law for Change in the Tax Burden (Legislative Amendments), based on the recommendations in the Tax Section of that report, was published, after being approved in a third reading in the Israeli Knesset.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The main changes of the new law regarding corporate income taxes are as follows:</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">1. Cancellation of the planned gradual reduction of income taxes and corporate income taxes commencing in 2012.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">2. Increase of the corporate income tax rate to 25% in 2012.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">3. Increase of the capital gains tax rate and betterment tax rate to 25%.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">Such tax rate changes have no significant impact on the Company's financial statements<font style="font-family: times new roman, times, serif;">.</font></p><p style="margin: 0px 0px 0px 56.7pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B.</td><td style="text-align: justify;">Tax laws applicable to the income of the Subsidiary:</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><u>Income Tax (Inflationary Adjustments) Law, 1985</u>:</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">According to the law, the results for tax purposes are measured based on the changes in the Israeli Consumer Price Index ("CPI").</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><u>The Law for the Encouragement of Capital Investments, 1959 ("the Law"):</u></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">According to the Law, BCT is entitled to various tax benefits by virtue of "beneficiary enterprise" status granted, as defined by this Law.</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">In March 2005, the Israeli Parliament passed the Arrangements Law for fiscal year 2005, which includes a broad and comprehensive amendment to the provisions of the Law ("Amendment No. 60 to the Law").</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The principal benefits by virtue of the Law are:</p><p style="margin: 0px 0px 0px 141.75pt; font: 10pt times new roman, times, serif; text-indent: -56.7pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Tax benefits and reduced tax rates under the Alternative Track of Benefits: </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">The Company is tax exempt for a benefit period of two years and in the five/eight subsequent years of the benefit period is subject to a reduced tax rate of 10%-25%.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">On January 6, 2011, an amendment to the Law for the Encouragement of Capital Investment-1959 (the "Law") was published. The amendment has a substantial effect on the current provisions of the Law. The following are the major changes in the amendment:</p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt/90% times new roman, times, serif; text-align: left;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt/90% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"> </td><td style="width: 28.35pt; text-align: left;">1.</td><td style="text-align: left;">A company located in Preferred Area A can file for both grants and tax benefits.</td></tr></table><p style="margin: 0px; font: 10pt/90% times new roman, times, serif; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt/90% times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"></td><td style="width: 28.35pt;">2.</td><td style="text-align: left;">The requisites for benefits were changed with the most significant change that the minimum investment requirement was removed. In addition, the definition of approved entity was changed.</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"></td><td style="width: 28.35pt;">3.</td><td style="text-align: left;">The income attribution based on revenues was cancelled, the result is that an approved entity would be taxable on its entire income at a fixed rate.</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"></td><td style="width: 28.35pt;">4.</td><td style="text-align: left;">Tax exemption was cancelled.</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"></td><td style="width: 28.35pt;">5.</td><td style="text-align: left;">Dividend payable to Israeli corporations from preferred income would be tax exempt.</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 85.05pt;"></td><td style="width: 28.35pt;">6.</td><td style="text-align: left;">The Grant Rate out of the approved investment would be up to 24%.</td></tr></table><p style="margin: 0px 0px 0px 84pt; font: 10pt times new roman, times, serif; text-align: left;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">The Tax rates applicable to Approved Industrial Enterprise would be 6% and 12% for those located in Preferred Area A or elsewhere, respectively, with effectiveness for the taxable year 2 of 2015 and onwards. Prior to 2015, the following tax rates will be applicable:</p><p style="margin: 0px 0px 0px 113.4pt; font: 10pt/110% times new roman, times, serif; text-align: left;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;">For the years 2011-2012 10% and 15%, respectively and for the years 2013-2014 7% and 12.5%, respectively. The amendment to the law is not expected to have a material impact on the Company's consolidated financial statements.</p><p style="margin: 0px 0px 0px 113.15pt; font: 10pt times new roman, times, serif; text-indent: -28.1pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"></font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">C.</td><td style="text-align: justify;">Deferred income taxes:</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets are as follows:</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="font: 10pt times new roman, times, serif; margin-left: 85.05pt; width: 80%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-bottom: 1pt; width: 74%; text-align: left;">Operating loss carryforward</td><td style="padding-bottom: 1pt; width: 1%;"> </td><td style="width: 1%; border-bottom: black 1pt solid; text-align: right;"> </td><td style="width: 10%; border-bottom: black 1pt solid; text-align: right;">32,165</td><td style="padding-bottom: 1pt; width: 1%; text-align: left;"> </td><td style="padding-bottom: 1pt; width: 1%;"> </td><td style="width: 1%; border-bottom: black 1pt solid; text-align: right;"> </td><td style="width: 10%; border-bottom: black 1pt solid; text-align: right;">30,206</td><td style="padding-bottom: 1pt; width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="text-align: left;">Net deferred tax asset before valuation allowance</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">13,187</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">12,858</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1pt; text-align: left;">Valuation allowance</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(13,187</td><td style="padding-bottom: 1pt; text-align: left;">)</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(12,858</td><td style="padding-bottom: 1pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-bottom: 2.5pt; text-align: left;">Net deferred tax asset</td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">-</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">-</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2010, the Company has provided valuation allowances of $13,012 in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.</font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">D.</td><td style="text-align: justify;">Available carryforward tax losses:</td></tr></table><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;"> </font></p><p style="margin: 0px 0px 0px 85.05pt; font: 10pt times new roman, times, serif; text-indent: 0in; text-align: justify;"><font style="font-weight: normal;">As of December 31, 2010, the Company has an accumulated tax loss carryforward of approximately $12,716. Carryforward tax losses in the U.S. can be carried forward and offset against taxable income in the future for a period of 20 years. Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</font></p><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">E.</td><td style="text-align: justify;">Loss from continuing operations, before taxes on income, consists of the following:</td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"> </p><table style="font: 10pt times new roman, times, serif; margin-left: 85.05pt; width: 80%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" nowrap="nowrap" colspan="6">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td><td> </td><td style="text-align: center;" colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 11.35pt; width: 74%; text-indent: -11.35pt; text-align: left;">United States</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">(1,886</td><td style="width: 1%; text-align: left;">)</td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;">(1,235</td><td style="width: 1%; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 11.35pt; padding-bottom: 1pt; text-indent: -11.35pt; text-align: left;">Israel</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: left;"></td><td style="border-bottom: black 1pt solid; text-align: right;">(2,032</td><td style="padding-bottom: 1pt; text-align: left;">)</td><td style="padding-bottom: 1pt;"> </td><td style="border-bottom: black 1pt solid; text-align: right;"> </td><td style="border-bottom: black 1pt solid; text-align: right;">(1,165</td><td style="padding-bottom: 1pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #ccffcc;"><td style="padding-left: 11.35pt; padding-bottom: 2.5pt; text-indent: -11.35pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">(3,918</td><td style="padding-bottom: 2.5pt; text-align: left;">)</td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">(2,400</td><td style="padding-bottom: 2.5pt; text-align: left;">)</td></tr></table><p style="margin: 0px; font: 10pt times new roman, times, serif; text-align: left;"> </p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">F.</td><td style="text-align: justify;"><font style="font-weight: normal;">Due to the Company’s cumulative losses, the effect of ASC 740 as codified from ASC 740-10 (formerly FIN 48) is not material.</font></td></tr></table><p style="margin: 0px 0px 0px 113.4pt; font: 10pt times new roman, times, serif; text-indent: -28.35pt; text-align: justify;"><font style="font-weight: normal;"> </font></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">G.</td><td style="text-align: justify;"><font style="font-weight: normal;">BCT has not received final tax assessments since its incorporation.</font></td></tr></table><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 56.15pt;">NOTE 14 -</td><td style="text-align: justify;">TRANSACTIONS WITH RELATED PARTIES</td></tr></table><table style="font: 10pt times new roman, times, serif; margin-left: 56.7pt; width: 80%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" nowrap="nowrap" colspan="6">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2011</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="2">2010</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td style="font-weight: bold; padding-bottom: 1pt;"> </td><td style="font-weight: bold; border-bottom: black 1pt solid; text-align: center;" colspan="6">U.S. $ in thousands</td><td style="font-weight: bold; padding-bottom: 1pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="width: 74%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 1%;"> </td><td style="width: 1%; text-align: left;"> </td><td style="width: 10%; text-align: right;"> </td><td style="width: 1%; text-align: left;"> </td></tr><tr style="vertical-align: bottom;"><td style="padding-left: 28.35pt; padding-bottom: 2.5pt; text-indent: -28.35pt; text-align: left;"><b>A.        </b>Fees and related benefits and compensation expenses in respect of options granted to a member of the Board who is a related party</td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">150</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td><td style="padding-bottom: 2.5pt;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;"> </td><td style="border-bottom: black 2.5pt double; text-align: right;">318</td><td style="padding-bottom: 2.5pt; text-align: left;"> </td></tr></table><p style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; text-align: left;"></p><table style="margin-top: 0px; margin-bottom: 0px; font: bold 10pt times new roman, times, serif; width: 100%;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 56.7pt;"></td><td style="width: 28.35pt;">B.</td><td style="text-align: justify;"><font style="font-weight: normal;">As for transactions with Ramot, see Note 3.</font></td></tr></table>
<table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="text-align: justify; vertical-align: top;">
<td style="text-align: left; width: 56.7pt;">NOTE 3     -</td>
<td style="text-align: justify;">UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</td>
</tr>
</table>
<p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"> </p>
<p style="text-align: justify; text-indent: 0in; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;">The accompanying unaudited interim financial statements have been prepared in a condensed format and include the consolidated financial operations of the Company and its wholly-owned subsidiary as of March 31, 2012 and for the three months then ended, in accordance with accounting principles generally accepted in the United States relating to the preparation of financial statements for interim periods. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for the year ended December 31, 2012.</p><table style="margin-top: 0px; font: bold 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0">
<tr style="text-align: justify; vertical-align: top;">
<td style="width: 0%;"></td>
<td style="text-align: left; width: 56.7pt;">NOTE 7   -</td>
<td style="text-align: justify;">SHORT-TERM LOANS</td>
</tr>
</table>
<p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"> </p>
<p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;">In March 2007, the Company issued a $150 convertible note to a lender, with an annual interest rate of 8% for the first year, with an increase up to 10% after the first year. On January 27, 2010, the lender converted the entire accrued principal and interest of $189 into 1,016,109 shares of Common Stock of the Company. In July 2011, the Company issued to the lender an additional 309,977 shares of Common Stock of the Company with regard to the above conversion.</p>
<p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;"> </p>
<p style="text-align: justify; margin: 0pt 0px 0pt 56.7pt; font: 10pt times new roman, times, serif;">Since the outcome of the issuance of the shares was to relieve the debtor from its obligation, based on guidance in ASC 860-10 (formerly FASB No 140) and ASC 450-20 Extinguishment of Liabilities” the Company derecognized the liability with the difference recognized in earnings.</p>
3357000
1000
3356000
0
0
13327600
Out of the which, cash flows used in discontinued operating activities of $36, cash flows used in discontinued investing activities of $16 and cash flows provided in discontinued financing activities of $57, relating to the period from inception to March 31, 2004, is unaudited.
Out of which, $163, relating to the period from inception to March 31 2004, is unaudited.
Represents an amount less than $1.